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ABSTRACT 
The effect of a single subcutaneous injection of extended-release eprinomectin for parasite 
control on cow/calf performance was evaluated in a pair of studies. In the first study, a fall-
calving Angus herd was utilized. Mature cows were treated with either extended-release 
eprinomectin (EPR) or a conventional injectable anthelmintic (CONV). Cows treated with EPR 
had better maintenance of BCS through calving and into breeding. Subsequent pregnancy rates 
were greater for EPR than CONV cows. Furthermore, calves from EPR dams were younger at 
weaning, but had greater weaning weights than calves from CONV dams. From the same fall-
calving Angus herd, replacement heifers were either treated with EPR or CONV. Weights taken 
post-treatment demonstrated heavier BW, greater weight gain, and greater ADG, for EPR 
heifers. Both conception to AI and overall pregnancy rates were greater for EPR heifers. Also, a 
greater proportion of EPR heifers calved in the first 21 days of the subsequent calving season.  
 A second study was conducted to elucidate the effects of a single injection of extended-
release eprinomectin on economically relevant production variables in beef cows and calves as 
well as subsequent feedlot health, performance and carcass traits of calves. Animals from 13 
cooperator herds across 7 states were stratified within herd by cow age, calf birth date, calf birth 
BW, and calf sex and assigned to 1 of 2 treatments; injectable doramectin (DOR) or injectable 
extended-release eprinomectin (EPR). There was no difference in cow BW at the start or end of 
the grazing season, resulting in no differences in BCS, change in BW or ADG over the course of 
the grazing season. Fecal samples collected at treatment indicated no difference in fecal egg 
count (FEC) at the start of the grazing season. However, subsequent samples collected at the end 
of the grazing season showed lower FEC for EPR cows and a greater overall reduction in FEC 
over the course of the grazing season. EPR cows had a lower incidence of pinkeye, however, 
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there was no differences in calf pinkeye. Fly counts conducted indicate no difference in fly 
burden between treatment groups. There was no difference in reproductive success including 
conception to AI, overall breeding season pregnancy rates, calving interval, and calving 
distribution. There was no difference in calf treatment BW, weaning BW, or pre-weaning ADG.  
Following weaning, a subset of calves from each herd at the discretion of the cooperator 
were shipped to Tri-County Steer Carcass Futurity (TCSCF) for the finishing phase. At initiation 
of the feeding phase, calf BW did not differ. While EPR calves tended to be heavier at re-
implantation, final BW and overall ADG were not different between treatments. Despite a lack 
of differences in feedlot performance, morbidity was lower for EPR calves indicating these 
calves were healthier throughout the feeding phase. However, evaluation of carcass performance 
showed no difference in HCW, dressing percent, backfat, KPH, REA, YG or marbling score. 
Analysis of quality grade indicated higher average quality grade for EPR calves as well higher 
percentage of calves that graded average choice or higher. There were no differences in the 
percentage of steers that graded low choice or lower.  Economic analysis indicates an 
opportunity for producers operating on a retained ownership platform who treated with EPR to 
realize a profit above the initial cost of treatment through improved health status during the 
feeding phase. An overall lack of performance differences observed in the current study may 
likely be a function of low FEC in participating herds. 
 In summary, results from these studies indicate that certain environmental conditions can 
result in improved performance following treatment with extended-release eprinomectin. 
Benefits from anthelmintic administration to suckling calves pre-weaning may extend to the 
feedlot phase. Opportunities to capitalize on initial treatment investment are evident, but are 
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dependent on the size of the production response and the economic conditions at time animals 
are marketed. 
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CHAPTER 1.   
INTRODUCTION 
All grazing animals are exposed to parasites and acquire some level of parasitic infection 
throughout the grazing season. If not managed properly, these parasites result in costly 
consequences to both animal health and a producer’s bottom line (Hawkins, 1993). 
Gastrointestinal parasites are estimated to cost the U.S. cattle industry approximately $3 billion 
annually (Bagley et al., 1998). However, the costs of parasitism are difficult to quantify as 
infections are typically subclinical in nature. Gastrointestinal parasites can create nutritional 
inefficiencies in livestock and greatly reduce performance resulting in economic losses (Bagley 
et al, 1998). The resulting losses from subclinical infections are subtle yet costly to the beef 
industry. 
While parasites pose a potentially severe health risk, pharmaceutical intervention in the 
form of anthelmintic treatment has been proven to reduce worm burdens in cattle and improve 
performance across all segments of the beef industry. Deworming during the grazing season has 
been shown to improve cow/calf production parameters including calf performance, cow 
performance, reproductive success, and milk production (Stuedemann et al., 1989; Wohlgemuth 
et al., 1990; Stromberg et al., 1997; Hersom et al., 2011). Furthermore, deworming has been 
implicated for improved lifetime performance and health for both replacement heifers and 
feedlot animals (Mejia et al., 1999; Clark et al., 2013, 2015). Although highly advantageous for 
producers, a large portion of the cowherd is never dewormed including unweaned calves (38%), 
replacement heifers (25%), weaned calves (41%), and mature cows (13%) (NAHMS, 2008).   
Anthelmintic technologies have long been used in animal agriculture and have been a 
stable in ruminant production systems (Sutherland and Scott, 2010). The development began in 
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the 1960’s and continued through the late 1990’s with the arrival of newer, more effective 
products (McKellar and Jackson, 2004). Most products currently available have a range of 
effectiveness from 28 to 35 days. While these products have broad-spectrum action, and come in 
convenient dosing forms, they are short-duration treatment options.  
Few developments for alternative or new anthelmintic technologies have been made in 
the last decade. However, in 2012, Merial, Inc. released the extended-release version of their 
injectable anthelmintic drug, eprinomectin. This product label claims 100-150 days of parasite 
protection with one injection. Research analyzing plasma concentration of eprinomectin over the 
extended-release period shows effective plasma concentrations up to 150 days post-
administration (Solls et al., 2013). While this product has proven to reduce worm burdens and 
improve weight gains, investigations have been primarily made into the stocker segment of the 
beef industry (Rehbein et al., 2013a; Rehben et al., 2013b, Clark et al., 2014). Little research has 
been focused on other production setting including cow/calf and feedlot. Therefore, the 
development of a newer, novel anthelmintic warrants investigation into its effects in alternative 
production systems as well as its impact on reproductive success, as this has been largely 
understudied in response to anthelmintic treatment.  
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CHAPTER 2.  LITERATURE REVIEW 
2.1 Introduction 
The goal of this literature review is to describe the parasites found in ruminants, their 
impact in grazing animals, as well anthelmintic products available and to help control parasites. 
Finally, the impact of animal performance following anthelmintic treatment and the economic 
implications associated with anthelmintic treatment will be described.  
 
2.2 Common parasites in cattle 
Parasitism is equal to the summation of effects from all gastrointestinal nematodes (GIN) 
species and stages present in the host at any given time (Sutherland and Scott, 2010). There is a 
diverse variety of GIN that infect cattle and their effects on cattle health and productivity are 
equally diverse and pose the greatest health threat to grazing cattle. Gastrointestinal nematodes 
are species-specific to the host they inhabit and their ability to develop to an infectious stage is 
highly dependent on a multitude of environmental factors including temperature, humidity, 
pasture type, pasture management, and grazing behavior (Stromberg and Gassbarre, 2006; Fox et 
al., 2013).  While most parasite species have a life cycle of approximately 6-8 weeks, longer 
grazing seasons can facilitate recycled infections, which increase worm burdens (Williams and 
Loyacano, 2001). 
 
2.2.1 Parasite life cycle 
While variations exist between species of parasites, the general life cycles for GIN in 
cattle are largely similar (Zajac, 2006; Sutherland and Scott, 2010; Ballweber, 2014). GIN can 
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live both on pastures and within their host, however, an entire lifecycle cannot be carried out in a 
single location (Zajac, 2006; Sutherland and Scott, 2010).  
A nematode lifecycle begins when an egg, produced by an adult within the host, is 
expelled into the environment via fecal excrement (Sutherland and Scott, 2010). Typically, 
within 24 hours of being excreted, eggs will hatch into their first larval stage (L1; Ballweber, 
2014). Following hatching from the egg, L1 larvae will undergo two molts as it develops to the 
second larval stage (L2) followed by the third larval stage (L3; Zajac, 2006).  
While a large amount of eggs may be deposited onto the pasture, a very small percentage 
actually develop to an infective stage, estimated in a range from 3% to 30% depending on 
species and environmental impacts (Ciordia and Bizzell, 1963; Williams and Bilkovich, 1971). 
This survival rate is strongly impacted by a number of highly variable factors. Two of these 
factors of considerably great importance are temperature and humidity (Armour, 1980; 
Stromberg, 1997; Stromberg and Gasbarre, 2006; Yazwinski and Tucker, 2006, and Taylor et al., 
2007). Both of these factors have been strongly implicated in development, survival, migration, 
and infectivity of GIN (Ciordia, and Bizzell, 1963; Armour, 1980; Stromberg, 1997; Stromberg 
and Gasbarre, 2006; Yazwinski and Tucker, 2006, and Taylor et al., 2007). A range between 6° 
C and 32° C has been established with an optimum temperature of 25° C for development of the 
free-living stages nematodes (Ciordia and Bizzell, 1963). While humidity in the air is important, 
other sources of moisture including moisture in the manure pat itself, the soil, the vegetation, and 
drainage all play an important role in the GIN life cycle (Armour, 1980). The survival of free-
living GIN and overall lifespan of GIN is also greatly impacted by nutritional status of the 
parasite (Klass, 1977; Yazwinski and Tucker, 2006; Sutphin and Kaeberlein, 2008). Most 
interestingly, studies have noted a negative correlation between nutritional status and lifespan 
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such that nutritional restriction increases lifespan (Klass 1977; Sutphin and Kaeberlein, 2008). 
The mechanisms for this correlation are not well understood but are believed to be founded in 
decelerated aging process (Sutphin and Kaeberlein, 2008). These optimum conditions for 
longevity are an interesting contrast to the environment found within the host they inhabit.  
Migration of the L3 larvae is extremely important for transmission to the host as well as 
subsequent survival and development into the adult stages (Stromberg and Gasbarre, 2006). 
There are a number of environmental factors that play a role in the migration of L3 larvae 
including pasture-type, topography, drainage, pasture management, grazing behavior and 
moisture which all impact GIN ability to migrate away from manure pats and onto surrounding 
herbage for uptake into the host (Stromberg and Gasbarre, 2006; Fox et al., 2013). A continuous 
film of moisture on the herbage is imperative to larval migration away from the fecal pat and to a 
location where it can be ingested by the host (O’Connor et al., 2006). While potentially not a 
factor for more hardy species that can withstand dry conditions (Silva et al., 2008) time of day 
could potentially impact larval migration (Krecek et al., 1995). Increased moisture in the 
morning and evening have been shown to increase larval migration during these times and 
possibly increase infection risk in grazing animals (Krecek et al., 1995; Chaudary et al., 2008). 
Also, height of pasture being grazed can play a role in risk of GIN infection for grazing animals. 
When grass is adequate, cattle can selectively graze areas away from fecal pats that have 
concentrated parasite populations (Stromberg and Gasbarre et al., 2006; Fox et al., 2013). 
However, when pasture resources are limited, cattle cannot be as selective which may increase 
infection risk (Fox et al., 2013).  
Grazing management can be implemented to control uptake of parasites on pasture and 
help mitigate risk of infection to grazing livestock. Limiting the length of the grazing season or 
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amount of grazing time per day can reduce parasite intakes in grazing animals (Charlier et al., 
2005; Yazwinski and Tucker, 2006). Different types of forage have also been implicated in 
reducing the ability of parasites to migrate and therefore be ingested by the host (Morely and 
Donald, 1980; Yazwinski and Tucker, 2006; Fox et al., 2013) where pasture species with higher 
moisture retention may contribute to greater larval migration (Niezen et al., 1998; Amaradasa et 
al., 2010). Herbage species that contain natural anthelmitic compounds may reduce larval 
migration (Niezen et al., 1998).  Maintaining adequate pasture resources can also reduce 
exposure of livestock to concentrated GIN populations on livestock by dilution of contamination 
(Brundson, 1980; Stromberg et al., 2006; Fox et al., 2013). Resting pastures can allow natural 
removal of parasites by environmental factors without reinfection by grazing animals (Morely 
and Donald, 1980; Brundson, 1980). In the wake of anthelmintic resistance, which will be 
discussed, grazing management is an important source of biological control of GIN populations 
on pasture and subsequent infection in grazing livestock.  
The parasitic phase of the GIN life cycle cannot begin until the L3 larvae  interacts with 
the host which usually occurs by ingestion of GIN by the host from herbage while grazing. Soon 
after ingestion, L3 larvae reside in their respective intestinal area where they will exert their 
parasitic effect (Stromberg and Gasbarre, 2006). In the same manuscript, authors identified that 
shortly after reaching the area they will primarily affect, they develop into an immature adult 
(L4) stage. It is at the stage (L4) that some species of worms are able to arrest their development 
in a process called hypobiosis (Sutherland and Scott, 2010). While the mechanisms of hypobiosis 
are not well understood, some factors believed to trigger this arrest stage are immune status of 
the host, season or climate, and possibly response to alterations in hormones (Sutherland and 
Scott, 2010).   It has been suggested that hypobiosis is a mechanism by which GIN can 
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synchronize their life cycle with current conditions, either in the host or external environment 
(Michel, 1976). While hypobiosis occurs during adverse conditions, ingestion of arrested, less 
pathogenic larvae has been implicated as a mechanism for lessening the impact of parasitic 
infection by storing dormant larvae instead of pathogenic adults (Schad, 1977). After a period of 
hypobiosis, resumption of development of inhibited larvae can account for the occurrence of 
clinical parasitic infection in animals who have not been recently exposed to contaminated 
pasture (Armour and Duncan, 1987).   
 If there is no arrest stage, GIN will develop into reproductively mature adults within 2 to 
4 weeks of ingestion of the L3 stage and will begin producing eggs to be excreted in the feces 
(Ballweber, 2014). This time between ingestion of the L3 larvae and subsequent detection of eggs 
in the feces is termed the pre-patent period and is dependent on species and host environment 
(Sutherland and Scott, 2010; Ballweber, 2014).  
 Other limitations to lifespan are host immunity. Initially, established worms may not be 
effected, but subsequent ingested GIN lifespans may be impacted once an immune response by 
the host has been mounted (Sutherland and Scott, 2010).  Primary parasitic infections have been 
shown to block host immune response (Behnke et al., 1983). Studies down with Ostertagia 
ostertagia infections in cattle have demonstrated suppression of lymphocyte reactivity as well as 
suppressed cellular and antibody responses during initial stages of parasite infection (Klesius, 
1988). However, subsequent infections allow for a mounted immune response by the host and 
can influence secondary GIN infections (Keymer and Hiorns, 1986).  
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2.2.2 Gastrointestinal nematodes in cattle 
While a large number of GIN have been isolated from domesticated cattle, only a small 
portion are considered clinically significant from a veterinary perspective (Yazwinski and 
Tucker, 2006). In the following discussion, GIN of veterinary importance will be presented and 
GIN will be grouped by the area of the GI tract that they primarily affect. 
 
2.2.2.1 Abomasum. Ostertagia ostertagi, also known as the brown or medium stomach 
worm, is considered to be the most economically important parasite of cattle raised in temperate 
climates (Yawinski and Tucker, 2006; Irsik, 2012). This parasite is able to arrest its development 
which allows it to evade immune regulation by the host and lengthens the time of infection 
(Armour and Duncan, 1987; Klesius, 1988; Yazwinski and Tucker, 2006). Two clinical forms of 
O. ostertagi have been identified: type I disease and type II disease (Smith and Grenfell, 1985; 
Fox, 2016). Type I disease, typically found in in calves and yearlings, is caused by larvae that do 
not experience a developmental arrest period and occurs shortly after ingestion of larvae (Smith 
and Grenfell, 1985; Fox et al., 2016). Type II disease is caused by larvae that have experienced 
an arrest stage in their development and, therefore, most typically occurs in older cattle (Smith 
and Grenfell, 1985). Some research has indicated that arrested larvae will resume development in 
conditions when host immunity is compromised (Armour and Duncan, 1987). Clinical symptoms 
of both types of infection are by weight loss, reduced appetite, and diarrhea. Because symptoms 
are similar, the type of infection can only being distinguished by timing of outbreak following 
ingestion (Smith and Grenfell, 1985).  As previously discussed, initial infection with O. 
ostertagi, as in other species of GIN, can suppress immune response in young animals (Klesius, 
1988). While acquired immunity is eventually achieved, it may not be until an animal’s second 
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Grazing season that they are able to effectively reduce worm burdens naturally and cattle may be 
susceptible to subclinical reinfection throughout their lifetime (Herlich, 1980; Klesius, 1988). 
Another worm is the Trichostrongylus axei, also known as the stomach hairworm. While 
its prevalence is considerably less than other GIN discussed, being found in less than 10% of 
sampled populations, it remains of veterinary importance because it is not limited by age of host 
or previous exposure (Yazwinski and Tucker, 2006). Clinical symptoms of these GIN include 
gastritis, hyperemia, diarrhea, protein loss, and anorexia and weight loss (Fox, 2016).   
Also known as the barber pole, large stomach worm, twisted stomach or wire worm, 
Haemonchus contortus are hematophagic parasites and are the largest, most pathogenic parasite 
of the ruminant species (Yazwinski and Tucker, 2006; Sutherland and Scott, 2010; Irsik, 2012). 
Contributing to their pathogenicity is their extensive genome with highly adaptive genotypic 
capabilities to selection, long generation time, and high rate of reproduction (Prichard, 2001; 
Yazwinski and Tucker, 2006). Also contributing to its pathogenic effect is its ability to arrest 
development in the early L4 stage (Anderson, 2000). Not only does this stage of arrest allow for 
survival during suboptimal conditions, it has also been implicated as a mechanism of resistance 
to parasiticides (Anderson, 2000). Clinical signs of infection with Haemonchus spp. include poor 
body condition, stress, progressive anemia, pallor of the skin and mucus membranes, and 
submaxillary edema (bottle jaw) depending on the extent of blood lose and the severity of 
infection (Bowman, 1999).  
  
2.2.2.2. Small Intestine. Of the phylum Cooperia, several species exist with Cooperia 
oncophora, Cooperia punctate, and Cooperia pectinate being the most predominant (Yazwinski 
and Tucker, 2006; Sutherland and Scott, 2010; Irsik, 2012). This parasite is found in the 
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proximal region of the small intestine and is most burdensome to animals three years of age and 
younger, causing damage and inflammation to the lining of the GI tract resulting in leakage and 
loss of blood protein (Williams and Loyacano, 2001; Yazwinski and Tucker, 2006). Clinical 
signs in Cooperia are very similar to its abomasal counterpart Trichostrongylus (Bowman, 
1999). While Cooperia have been considered less important compared to other nematodes due to 
low degree of pathogenicity as well as a rapid development of immunity against this parasite by 
the host by the second grazing season, recent observations of resistance to macrocyclic lactones 
have increased their attention and importance (Njue and Prichard, 2004; Yazwinski and Tucker, 
2006)    
Nematodirus helvetianus, generally termed the thread-necked worm, deviates from the 
previously discussed life cycle of nematodes because it remains inside the egg until it develops 
to the L3 stage instead of hatching into the L1 stage like other GIN (Yazwinski and Tucker, 2006; 
Sutherland and Scott, 2010). Development within the egg has been implicated in longevity of 
free-living N. helventianus through multiple grazing seasons in cooler regions (Gibbs, 1980). At 
doses of anthelmintic treatment below the label recommended dose, N. helvetianus are resistant 
to macrocyclic lactones, much like Cooperia and are thus called a dose-limiting species 
(Yazwinski and Tucker, 2006). However, unlike with Cooperia, hosts are able to mount a rapid 
immune response as yearlings, mitigating low efficacy of parasiticides with this species 
(Yazwinski and Tucker, 2006). The main clinical sign of infection is severe and debilitating 
diarrhea (Bowman, 1999).    
 
2.2.2.3 Large Intestine. Fewer gastrointestinal nematodes reside in the large intestine. 
Oesophagostomum radiatum, sometimes referred to as the nodular worm, are mostly pathogenic 
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in the larval stage (Sutherland and Scott, 2010). These GIN burrow into the mucosal layer of the 
distal small intestine and proximal large intestine and result in clinical signs of diarrhea at the 
time of worm emergence from the mucosal layer (Yazwinski and Tucker, 2006; Sutherland and 
Scott, 2010). These GINs are of veterinary importance because of a lack of acquired immunity 
by the host resulting in a constant, light infection (Yazwinski et al., 1999; Yazwinski and Tucker, 
2006). While acquired immunity of the host may not be possible to control infections of this 
species, anthelmintic treatment is highly effective in eliminating infections of O. radiatum 
(Yazwinski et al., 1999).   
 
2.2.3 Epidemiology 
As previously expressed, a diverse population of GIN can infect hosts and exert equally diverse 
impacts in several locations throughout the gastrointestinal tract. As mentioned previously, 
parasitic infection is equal to the summation of all the species and stages of parasites present 
(Sutherland and Scott, 2010) and must be considered when determining epidemiology of 
parasitic infections. Epidemiology is an area of medicinal study that focuses on incidence, 
distribution, and possible control of disease. The study of parasite epidemiology is typically 
evaluated by population dynamics as suggested by Gordon (1948) because a threshold at which a 
worm burden becomes dangerous is not and cannot be defined in animals.  This approach of 
population dynamics is also necessary because resulting infections are usually subclinical and 
have a less noticeable onset than other epidemics or diseases. Overriding determinants include 
climate, weather, season and region (Yazwinski and Tucker, 2006) where climate appears to 
determine the prevalence of parasites and weather appears to effect timing of parasitic outbreaks 
(Craig, 1979; Yazwinski and Tucker, 2006). Parasitic outbreaks are most common when the 
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following conditions occur: large larval prevalence in the envrionment, poor host nutrition, and a 
poor immunological response to infestation (Roberts et al., 1952).  
 Outbreaks of parasitic disease can arise for the following reasons: 1) increase in parasite 
populations and therefore increased infecting mass, 2) an alteration in susceptibility of the host, 
3) the introduction of susceptible stock to an already infested area, and 4) the introduction of 
infected stock into a clean environment (Gordon, 1948; Armour, 1980; Taylor et al., 2007). 
Integral to understanding parasitic infection and transmission in the these four scenarios is an 
understanding of a multitude of interactions and factors that play large roles into the 
epidemiological impact of parasites. These including parasite-pasture interactions (Armour, 
1980; Stromberg and Gasbarre, 2006), parasite-host relationships (Armour, 1980; Stromberg and 
Gasbarre, 2006), environmental factors (Armour, 1980; Fox et al., 2013), pasture management 
(Armour, 1980; Stromberg, 1997; Fox et al., 2013), and host behavior (Armour, 1980; Stromberg 
and Gasbarre, 2006; Fox et al., 2013).    
 
2.2.4 Parasite-host relationship 
 While all of the aforementioned factors influence epidemiological impact of parasites in 
beef cattle, producer concerns focus on parasite-host relationships and factors affecting worm-
burden of individual animals as these are the primary source of economic loss in production 
settings (Stromberg and Gasbarre, 2006). Once infective larvae are ingested by the host, factors 
that impact the parasite’s ability to cause disease can vary greatly between and within herds 
(Gasbarre et al., 2001).  
Host immune status is one of the most important lines of defense against parasitic 
infection. It has been well defined that the immune response in cattle occurs via a Th2 response 
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(Svetic et al., 1993; Claerebout and Vercruysse, 2000; Gasbarre et al., 2001). This response 
releases helper-T cells in the wake of helminth infection stimulates a cascade release of a host of 
immune molecules including cytokine Interleukin 4 (IL4), IgG1, and IgE antibodies along with a 
large number of mast cells, but is not controlled by a single mechanism (Svetic et al., 1993; 
Gasbarre et al., 2001). The ability to mount an immune response to a helminth infection is 
dependent on a number of animal related factors. 
Due to the location and pathogenic nature of GIN within the animal, a definite, 
established link has been made between parasite infections and nutritional status of the host 
(Armour, 1980; Coop and Kyrazakis, 1999; Sutherland and Scott, 2010). Nutritional status of the 
host during a parasitic infection can be evaluated from two perspectives: metabolic cost of 
disturbances caused by parasitism and the effect of nutritional status of host on ability to mount 
an immune response (Coop and Kyriazakis, 1999; Sutherland and Scott, 2010). The first 
perspective will be discussed in a subsequent section, whereas a discussion on the latter will be 
presented now. Gastrointestinal parasites can compromise the nutritional status of an animal. 
However, during a parasitic infection, infected animals are also mounting an immune response, 
further impacting nutrient requirements. In fact, Poppi et al. (1988) found that the nutritional 
penalty of parasitic infection was most severe during weeks 11 – 13 when animals appeared to be 
resisting larval challenge. The results from this study suggest that the nutritional cost of 
immunity to parasitic infections is greater than that associated with a primary infection.  
Studies in sheep have demonstrated reduced production response of parasitized animals is 
associated with sequestration of protein in tissues of the gastrointestinal tract (Wang et al., 1998; 
Yu et al., 2000). These studies have implicated tissue repair as well as the production of acute 
phase proteins in gut mucosa as possible explanations for protein accumulation in the GI tract. 
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Symons and Jones (1975) noted increased liver protein synthesis in parasitized animals when 
compared to pair-fed controls, which is indicative of acute phase response to infections. Other 
studies have demonstrated competition for certain amino acids between immune function and 
wool growth in animals selected for high wool production (Miller et al., 1998) suggesting 
potential nutritional trade-offs between immunity and production. Other studies have 
demonstrated that carcasses of parasitized animals contain less protein than uninfected controls 
indicating a slower rate of muscle protein synthesis and a faster rate of whole-body protein 
catabolism (Symon and Jones, 1975; Sykes, 1983; Entrocasso et al., 1986).  
 While immunity may create high nutritional demand for parasitized animals, studies 
have shown that high levels of protein supplementation can impact response to a parasitic 
infection by improvement in clinical signs, reduction in fecal egg counts, enhanced onset of 
immunity and increased resistance to re-infection (Bown et al., 1986; Abbot et al., 1988; Houkijk 
et al., 2006).  
Other factors that can impact host resilience to parasitic infection are sex, age, and 
previous infection of stock. Some work has demonstrated significantly higher egg counts in 
intact males than in their castrated or female counterparts (Copeman and Hutchinson, 1979; Herd 
et al., 1992) which can be considered when choosing parasite control programs. Exposure to 
infection for the purpose of acquired immunity and age of the animal go hand-in-hand. While 
young calves are impacted most severely by parasitic infection, acquired immunity to most GIN 
species is typically develops as the animal matures (Smith and Archibald, 1968; Yazinski and 
Tucker, 2006; Taylor et al., 2007). While difficult to quantify, research has suggested that a 
propensity for resistance to parasitic infection may be related to genetic differences between 
animals (Leighton et al., 1989; Gasbarre et al., 2001). Using fecal egg counts as a phenotypic 
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indicator, genetic differences associated with these phenotypes are under current investigation 
(Gasbarre et al, 2001).  Leighton et al. (1989) have indicated that sires can influence FEC of their 
offspring and have suggested that FEC have a heritability of 29%. Further investigation into 
genetic markers may one day provide producers an opportunity to help curb parasitic infection 
through targeted genetic selection  
 
2.3 Anthelmintic treatment 
 As previously discussed, parasitic infections are multifactorial in nature. The 
pathology of disease is based on interactions between the host, environment, and the parasite and 
is highly influenced by individual management strategies (Charlier et al., 2015). While there is 
no one-size-fits-all treatment recommendation, strategic treatment programs are proposed in 
order to identify crucial interactions between environment and host in order to offer the best 
protection for all classes of cattle (Stromberg and Gasbarre, 2006). While past applications of 
deworming technologies have had a therapeutic focus, integrated programs today focus on 
utilizing biological and chemotherapeutic control methods simultaneously (Brundson, 1980; 
Williams and Loyacano, 2001). Such control methods put an emphasis on strategically-timed 
treatments which are designed to not only prevent clinical parasitic infections but also reduce 
pasture contamination and subsequently lower future risk of infection (Williams and Loyacano, 
2001).   
 Crucial to implementing an effective chemotherapeutic control program is understanding 
regional climates and weather patterns (Williams, 1997; Williams and Loyacano, 2001; 
Stromberg and Gasbarre, 2006). Length of growing season, length of grazing season, and 
weather patterns optimal for nematode development and survival can impact risk of parasitic 
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infection (Williams, 1997). The goal for strategic treatment methods is reduce larval 
contamination on pasture (Brundson, 1980). This strategically timed control method requires an 
understanding of climate/environment/parasite interactions in order to target periods where 
treatment will be most effective (Southcott et al., 1976; Brundson, 1980; Williams and 
Loyacano, 2001). 
 While climate and environment effect the timing of anthelmintic treatment, the class of 
livestock may affect frequency of treatment. Susceptibility of an animal varies with age (Smith 
and Archibald, 1968; Yazinski and Tucker, 2006; Taylor et al., 2007), sex (Copeman and 
Hutchinson, 1979; Herd et al., 1992), previous exposure to parasitic infection (acquired immune 
function), and stage of production, as it effects nutritional requirements (Armour, 1980; Coop 
and Kyrazakis, 1999; Sutherland and Scott, 2010). Especially in environments with extended 
periods of infection risk such as temperate climates, multiple treatments for more highly 
susceptible stock may be necessary to provide adequate protection from parasitic infections 
(Williams and Loyacano, 2001).  
 While these proposed strategic treatment regimens effectively optimize animal 
performance and provide clean pastures for grazing animals by removing parasites, there is 
mounting concern that continued, long-term use of existing anthelmintics will result in high 
proportions of resistant nematode populations and drastically reduce the efficacy of chemical 
compounds used to control internal parasitic diseases. A management strategy known as the 
refugia concept, has sparked high interest due to rising incidence of anthelmintic resistance, 
particularly in small ruminants (Besier, 2012).  This concept will be discussed in depth later in 
this review. 
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 Although recommended anthelmintic control programs aim to optimize efficiency, and 
subsequently, return on investment, based on environment and host variables, there are several 
other factors that may drive management strategies utilized by producers (Charlier et al., 2015). 
Although producers are business-minded, intrinsic factors such as management, tradition, 
attitude, and social norms can all play roles into the types of parasite control implemented into a 
production system (Charlier et al., 2015) and therefore, must be decided at the farm level.   
 
2.4 Current anthelmintic treatments 
 As previously mentioned, anthelmintic treatment has an important role in a 
parasite control program and can be highly effective in conjunction with biological control 
methods. The physiological and biochemical differences between helminths and their host make 
the action of most commonly used anthelmintic drugs selectively toxic to the parasites without 
harming the host (Saz and Bueding, 1996; Kohler, 2001). Commonly, anthelmintic drugs effect 
three biochemical and physiological areas (Kohler, 2001). Target sites of these drugs are 
exclusively proteins including ion channels, enzymes, structural proteins and transport molecules 
(Kohler, 2001). The World Association for the Advancement of Veterinary Parasitology 
(W.A.A.V.P.) defines a new anthelmintic drug as economically successful if the product has 
broad spectrum, effective activity on all major nematodes at all stages or fulfills a specific niche 
in parasites not controlled by current anthelmintic products (W.A.A.V.P., 1995). Great strides 
made from the 1960’s to the 1990’s have deemed it the ‘golden age’ of chemotherapeutic drugs 
including several novel anthelmintic products (Geary et al., 2004; Waller, 2006). With this 
pharmaceutical evolution came several new and improved anthelmintic products with increased 
efficacy at lower dose rates than the one before it (McKeller and Jackson, 2004; Waller, 2006). 
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Development of these new drugs allowed safe, easy and effective protection against a broad 
spectrum of parasites at an affordable cost and increased popularity and use of parasiticides 
worldwide (Waller, 2006). The following discussion is focused on two of the main classes of 
anthelmintic molecules: benzimidazoles and macrocyclic lactones. Although other classes do 
exist, their market share is relatively small compared to the benzimidazoles and macrocyclic 
lactones and therefore will not be discussed.  
 
2.4.1 Benzimidazoles 
 The class of drugs known as the benzimidazoles consists of a large group of drugs 
(thiabendazole, parbendazole, oxibendazole, fenbendazole, oxfendazole, albendazole, 
traclabendazole, and ricobendazole) that are relatively insoluble and are most typically 
administered orally (Taylor et al., 2007). Through oral administration, the lowly soluble 
benzimidazole compounds are deposited directly into the rumen where low pH provides strong 
reducing conditions (Hennessy, 1993). The reduced metabolites that exit the rumen are more 
soluble than the parent compound and therefore have greater absorption (Hennessy, 1993). 
Another group called probenzimidazoles are metabolized to active benzimidazole metabolites, 
are included in this class (Taylor et al., 2007).  
Benzimidazole drugs bind with high affinity to tubulin, the microtubule subunit protein, 
and disrupts microtubule structure and function (Friedman and Platzer, 1978; Kohler and 
Bachmann, 1981; Lacey, 1988). Movement of chromosomes during cell division, skeletal 
structure, movement of intracellular particles, specifically energy metabolites, and exocytosis are 
the main functions of microtubules (Stryer et al., 2002). This process of inhibition is known as 
“capping” because it binds to the positive pole of polymerization and results in a slow onset 
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starvation due to inhibition of glucose uptake, protein secretion, and microtubule formation along 
with inhibition of egg production (Martin, 1997; Taylor et al., 2007). It also inhibits 
transportation of secretory granules within the cell cytoplasm, which results in cell lysis (Lacey, 
1988). While microtubules are found in animals, plants, fungi, and some bacterial cells (Stryer et 
al., 2002), the mode of action of benzimidazole drugs has selective binding only to nematode β-
tubulin (Martin, 1997).  
Starting in 1960, the first lower dose, high efficacy drug was introduced in the form of 
thiabendazole, and became a staple in small ruminant production, especially in Australia and 
New Zealand (Waller, 2006; Sutherland and Scott, 2010).  Throughout the 1970’s, several more 
molecules in the benzimidazoles class were developed and released as novel anthelmintic 
products (McKellar and Jackson, 2004). Some of these drugs included fenbendazole 
(Safeguard® and Panacur®), albendazole (Valbazen®) and oxfendazole (Synanthic®). These 
products come in various forms including oral drenches, blocks, in-feed formulation, or intra-
ruminal injection. All of these drugs have various withdrawal times and are effective on a range 
of parasites.  
 
2.4.2 Macrocyclic lactones 
 Macrocyclic lactones consist of the avermectins (ivermectin, doramectin, 
eprinomectin) and milbemycins (moxidectin). Chemically, avermectins vary from each other in 
side chain substitutions on the lactone ring, while milbemycins vary from avermectins by the 
lack of a sugar moiety on the lactone skeleton (Taylor et al., 2007). This class of drugs is highly 
active at low dose rates and is highly lipophilic resulting in slower release (Taylor et al., 2007).  
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The mode of action of avermectins is not fully understood. While it was originally 
believed that avermectins cause paralysis by stimulating the release of γ-aminobutyric acid 
(GABA) from nerve endings resulting in enhanced binding to its receptor on an excitatory motor 
neuron (McKellar and Jackson, 2004; Taylor et al., 2007), it is now known to potentiate the 
effect of GABA (Kohler, 2001; Sutherland and Scott, 2010). This enhanced binding creates an 
increased flow of chloride ions resulting in hyperpolarization of the cell (Taylor et al., 2007). 
More recent studies have indicated that the main mode of action of avermectins are exerted on 
glutamate-gated chloride channels (Kohler, 2001; McKellar and Jackson, 2004; Sutherland and 
Scott, 2010). The effect of drugs such as ivermectin are irreversible, causing hyperpolarization of 
the cell membrane and muscle paralysis (Kohler, 2001). This paralysis blocks pharyngeal 
pumping and inhibits feeding, which disrupts ingestion and causes starvation of the parasite 
(Geary et al., 1993; Sangster and Gill, 1999). Muscle paralysis can also affect mobility and 
reproduction (Prichard, 2001) giving this group of drugs multiple targets to exert its effects. 
Similar to benzimidazole drugs, macrocyclic lactones are selectively toxic to nematodes because 
the molecules are too large to cross the blood-brain barrier in mammals (Taylor et al., 2007), 
however, since macrocyclic lactones are neurotransmitter agonists, the onset of their effects are 
much quicker than their benzimidazole counterparts (Martin, 1997).  
The 1980’s brought the release of the macrocyclic lactones, referred to as endoectocides 
for their dual treatment of both internal (endo) and external (ecto) parasites (Williams and 
Loyacano, 2001; Taylor et al., 2007). One of the most popular drugs, ivermectin (Ivomec®), was 
released in the early 1980’s and is available as an injectable and a pour-on. Doramectin 
(Dectomax®), released in 1996 as a pour-on and injection as well as moxidectin (Cydectin®), 
released in 1998 as a pour-on are both products similar to Ivomec. In the late 1990’s 
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eprinomectin (Eprinex®) was released as a pour-on. All of these products range in length of 
effectiveness from 28 days to 35 days, making them short-range treatment options for parasite 
control. Recently, a long-acting eprinomectin injectable was released and has a length of 
effectiveness between 100 – 150 days.    
 
2.5 Anthelmintic resistance 
 While anthelmintic treatment can be highly effective at reducing or removing worm 
burdens in animals, as previously discussed, there are some concerns with a loss of effectiveness 
of these drugs due to developing resistance in nematode populations. Parasite resistance to 
anthelmintic drugs acquired through genetic transmission of a loss of drug sensitivity in 
previously sensitive worm populations (Kohler, 2001; Wolstenholme et al., 2004). While 
anthelmintic resistance in small ruminants is a prevalent, world-wide problem, reports of 
resistance in large ruminants have been scarce (Waller, 1994; Waller, 1997; Geary et al., 1999; 
Coles, 2002; Kaplan, 2004; Wolstenholme et al., 2004). The absence of anthelmintic resistance 
in cattle is believed to be due to management, immunity differences, and a lack of investigation 
into resistance (Coles, 2002; Kaplan, 2004).  While not a noted issue in North America, some 
strains of cattle GIN identified in other countries have demonstrated resistance to some broad-
spectrum anthelmintic drugs (Vermunt et al., 1995; Hosking et al., 1996; Stafford and Coles, 
1999; Mejia et al., 2003; Loveridge et al., 2003; Anziani et al., 2004; Gasbarre et al., 2009).  
There are several genetic processes that can play a role in a parasite’s ability to become 
resistant to certain anthelmintic drugs. Common genetic changes can either be caused by a 
mutation in a single gene or require a simultaneous mutation in many genes (Kohler, 2001; 
Wolstenholme et al., 2004; Sutherland and Scott, 2010) and can occur in circumstances of an 
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appropriate, therapeutic dose or under-dosing (Sutherland and Scot, 2010). These genetic 
adaptations for anthelmintic resistance are heritable (Lacey, 1988; Taylor et al., 2007), can either 
occur naturally in a population, or develop after exposure to anthelmintic treatment (Sangster, 
1999; Coles, 2002), and can result in a high number of resistant individuals with continued use of 
an anthelmintic (Taylor et al., 2007).  
 
2.5.1 Genetic resistance to benzimidazoles 
 Mechanisms of resistance in GIN to the benzimidazoles has been studied 
extensively. As previously discussed, benzimidazoles selectively target nematodes by binding 
only to nematode β-tubulin (Martin, 1997). Two isotypes have been identified for nematode β-
tubulin, type I and type II, each having separate genes (Kwa et al., 1993; Martin, 1997). 
Resistance to the benzimidazole drugs is the result of the loss of specific β-tubulin isotypes 
during selection resulting in alterations to β-tubulin isoforms (Prichard, 1994; Sangster and Gill, 
1999). Alterations to the isoforms due to the mutation prevents the drugs from binding to their 
intended target receptor (Lacey, 1988; Roos et al., 1990; Martin, 1997; Kohler, 2001; Sutherland 
and Scott 2010) and is associated with a structurally changed tubulin within the population (Roos 
et al., 1990). Lubega and Prichard (1991) have demonstrated that in benzimidazole resistant 
nematodes, only β-tubulin isoforms are altered and α-tubulin isoforms are unchanged, suggesting 
selection effects specific to benzimidazole exposure. Resistance is magnified because selection 
for resistant phenotypes occurs even without continued exposure to benzimidazoles (Roos et al., 
1990). Exacerbating the issue further is homozygous nature of the resistant genotype, which 
results in rapid, irreversible resistance (Roos et al., 1990).   
2.5.2 Genetic resistance to macrocyclic lactones 
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 The mechanism of resistance of GIN to macrocyclic lactones is complex and not 
fully understood. Because these drugs have multiple targets, it has been suggested that multiple 
genes are involved (Prichard, 2001; Wolstenholme et al., 2004; Sutherland and Scott, 2010). 
While patterns of resistance tend to vary both within and among species, common mechanisms 
of resistance include genes that encode specifically for pharyngeal and non-pharyngeal 
glutamate-gated chloride channel subunits and P-glycoproteins (Martin et al., 1997; Xu et al., 
1998; Sutherland and Scott, 2010). Mixed reports have found resistance to be caused by either a 
single gene mutation or essential, simultaneous mutations in multiple genes (Gill and Lacey, 
1998; Le Jambre et al., 2000). Because only isolated cases have been reported, it has been 
suggested a lack of wide-spread resistance is due to a necessary acquisition of multiple gene 
mutations in order to create a high level of resistance (Martin, 1997).     
 
2.5.3 Resistant nematode strains 
 Resistance to anthelmintic products is often detected by the failure of treatment 
with an anthelmintic to reduce egg shedding to an appropriate level (Bliss et al., 2008). Detection 
of reduced efficacy is most commonly measured using fecal egg count reduction tests (FECRT), 
which compares fecal egg counts before and after treatment with an anthelmintic to measure the 
reduction in or elimination of fecal egg shedding (Taylor et al., 2002; Coles et al., 2006). While 
universally used, limitations to this test have been noted. In some species of GIN, there is not a 
good correlation between fecal egg counts and worm counts and may over- or underestimate 
actual worm burden  (Taylor et al., 2002). Intermittent egg shedding and low egg output by adult 
nematodes and contribute to this low correlation (Taylor et al., 2002). Also, depending on the 
drug being studied, timing of fecal collection post-treatment may impact results (Taylor et al., 
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2002) A study in goats found that treatment with ivermectin can suppress egg production from 
days 10-14 and produce a false negative result if fecal samples are collected during this time 
(Jackson, 1993). Also, FECRT is not reliable if the proportion of resistant worms is less than 
25% (Coles et al., 2002). Despite noted limitations of this test (McKenna and Simpson, 1987; 
Coles et al., 1992; Waller, 1994; Taylor et al., 2002) it can be used for all classes of 
anthelmintics, is easy to execute, and feasible (Waller, 1994; Coles, 2006). In order to offset 
shortcomings of this test, guidelines have been recommended in order to standardize procedures 
universally (Coles et al., 1992). In 1982, the World Association for the Advancement of 
Veterinary Parasitology (W.A.A.V.P) set efficacy standards and established that treatment 
efficacies of 90% or greater were very good (Powers et al., 1982). However, a revision of these 
guidelines in 1995, after the introduction of more highly effective drugs, was raised to 98% or 
greater (Woods et al., 1995). According to resistance detection guidelines as determined by 
Coles et al. (1992), resistance is suspected if percentage reduction in egg count (efficacy of a 
product) is less than 95%.  
Using FECRT, several studies have reported anthelmintic resistance in several 
predominant and economically important strains of helminths. This resistance has been detected 
in several of the anthelmintic products currently used in cattle production. While the 
phenomenon is world-wide, it appears to be more widespread in countries in the southern 
hemisphere (Waller, 1997; Sutherland and Scott, 2010). Testing both macrocyclic lactones and 
bendimidazoles in the southeastern United States, Gasbarre et al. (2009) found varying degrees 
of reduced efficacies to moxidectin (82%), doramectin (62%), eprinomectin (42%), ivermectin 
(57%), and albendazole (69%) with a control group showing 54% reduction in egg counts. In this 
study, resistant strains were found in both Haeomonchus contortus with a smaller portion of 
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resistant population in Haemonchus placei. Also, strong resistance was found in Cooperia 
punctate with a smaller degree of resistance in Cooperia oncophore and Cooperia spatulata. In a 
national survey in the United States, Bliss et al. (2008) found reduced efficacies in a number of 
both injectable and pour-on formulations. However, they did note that combination use of 
products from different classes improved efficacy to an acceptable level.   
In a study conducted in the UK, Njue and Prichard (2004) found reduced efficacy of 
ivermectin (77%) and resistant strains of Cooperia oncophora. Studies in Argentina have 
indicated reduced efficacies to both injectable and oral formulations of macrocyclic lactones and 
benzimidazoles with  resistance in Haemoncus spp., Cooperia spp. Trichostrongylus and 
Ostertagia ostertagi (Fiel et al., 2001; Mejia et al., 2003, and Anziani et al., 2004). Similar 
reports in New Zealand indicate reduced efficacies of topical macrocyclic lactones with 
resistance found in C. oncophora and T. longispicularis (Loveridge et al., 2003).  
 
2.5.4 Management of nematode resistance 
 While resistance poses a threat to future ability of anthelmintics to be effective, there are 
management strategies that can be implemented in order to preserve anthelmintic efficacies. 
Refugia are a subpopulation of parasites that have not been exposed to, and therefore selected by, 
drug treatment (Van Wyk, 2001; Wolstenholme et al., 2004; McArthur and Reinemeyer, 2014). 
While refugia is comprised primarily of free-living nematodes, other conditions such as inhibited 
larvae or worms located in animals not treated can contribute to refugia within a population (Van 
Wyk, 2001; Wolsteholme et al., 2004; Sutherland and Scott, 2010). The refugia concept does not 
eliminate the chemical component of parasite control, but, by altering timing of dosing or 
reducing the number of animals treated, aims to dilute the number of resistant nematodes by 
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maintaining or increasing non-resistant nematode populations (Besier, 2012). The goal is to 
mitigate production losses due to parasitic diseases while maintaining efficacy of commonly 
used anthelmintic drugs (Besier, 2012). 
 Current, effective applications of refugia control programs can be commonly found in 
small ruminant production. Selective treatment strategies have been shown to successfully 
control worm burden, increase refugia, and reduce resistant populations in sheep and goat 
production world-wide without compromising animal efficiency (Hoste et al., 2002; Cringoli et 
al., 2009 Greer at el., 2009; Besier, 2010). While effective, control strategies based on refugia 
may require different or more laborious management techniques (Besier, 2012). Identifying 
animals to treat can be done via production responses or parasite burden based on fecal egg 
counts (Besier, 2012). Another identifier that can be used in sheep and goats is the FAMACHA 
system for identifying, specifically, haemonchosis (van Wyk and Bath, 2002). By inspecting the 
ocular membranes for anemia, animals suffering from homonchosis can be identified and treated 
individually rather than treating the whole herd (van Wyk and Bath, 2002). 
 Success of these programs in small ruminants have demonstrated that refugia-based 
treatment strategies can reduce the amount of treatments, increase refugia, and help preserve 
efficacy of popular classes of anthelmintic drugs without negatively impacting production 
parameters including growth, milk, and wool production (Hoste et al., 2002; Cringoli et al., 
2009; Greer at el., 2009; Besier, 2010; Besier, 2012). While anthelmintic resistance in cattle is 
less prevalent than that in small ruminants, implementation of these programs may one day be 
important to keeping resistance at bay and preserving efficacies of anthelmintics long-term.                
 Management of resistance is important. Consensus among the literature has concluded 
that reversion after a high degree of selection resistance is unlikely and thus, a permanent 
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condition (Kwa et al., 1993; Shoop, 1993; Sangster, 1999; Kaplan, 2004; Wolstenholme, 2004; 
Taylor et al., 2007). This conclusion establishes the need for progressive action for the future of 
anthelmintic control.    
Resistance is more prevalent in sheep and goats than in cattle and is most notably found 
in the southern hemispheres, specifically, Australia, New Zealand, South Africa, and South 
America (Taylor et al., 2007; Sutherland and Scott, 2010). A lack of ability for parasites to 
transfer between sheep and cattle is speculated to be the reason why the severity of resistance is 
less in cattle.  However, it is uncertain as to why resistance in cattle parasites is delayed while 
resistance in sheep parasites has made sheep production impossible in certain regions of the 
southern hemisphere (Sutherland and Scott, 2010). Presently, there appears to be no short-term 
solutions to anthelmintic resistance in currently used chemicals (Kaplan, 2004). While future 
alternatives include vaccines, new compounds, and non-chemical methods, preserving efficacy 
of currently effective drugs for as long as possible is important (Kaplan, 2004; Wolstenholme et 
al., 2004). 
2.6 Nutritional interactions 
 Even with concerns of resistance with current anti-parasitic drugs, anthelmintic treatment 
is still a highly effective method of mitigating the effects of parasitic infection in livestock. 
Essentially a ‘nutritional disease’, parasitic infections, if left unchecked, can create severe, long-
term consequences in infected animals. Based on altered nutrient requirements created both 
directly and indirectly by parasitic infections, depression in performance of parasitized animals 
often ensues. Coop and Kyriazakis (1999) suggested a nutrition partitioning framework within a 
host animal, in a growing animal, and in a reproducing animal. This framework advises that 
nutritional allocation during a parasite challenge may not be prioritized favorably to meet 
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production goals as well as mount an immune response. The authors propose that in a 
nutritionally limited environment, lowly prioritized physiological functions such as growth and 
reproduction along with immune acquisition and expression may be nutritionally limited, 
presenting trade-offs between parasitism and nutrition (Coop and Kyriazakis, 1999) thus 
effecting important production parameters. Other studies in cattle have also indicated a low 
priority of function for physiological processes, most notably reproductive activities such as 
estrous cycles and initiation of pregnancy (Short and Adams, 1988). It is reasonable to assume 
that in environments with impaired nutritional status, as is seen in parasitic infections, these 
important functions may be the first physiological processes to fail or be hindered in the wake of 
a parasitic infection. Because the presence of parasites in grazing animals is widespread and their 
eradication is extremely unlikely, understanding these interactions is of utmost importance and 
may play a large roll in implementing the best parasite control program in a herd.  
 
2.6.1 Nutritional consequences of parasitic infection 
 Parasitic infections create nutritional inefficiencies in the hosts that they infect. 
These inefficiencies are the result of mechanisms that impact nutrient uptake and nutrient 
utilization within the host. One of the most notable symptoms of parasitized animals is reduced 
feed intake (Sykes and Coop, 1977; Fox et al., 1989). While the mechanisms for reduced feed 
intake are not thoroughly understood, changes in metabolic hormones (Gibbs et al., 1973; Fox et 
al., 1989) disruption of signaling to the central satiety center (Dynes et al., 1990), alterations in 
rumen pH (Leng, 1981), and decreased rumen motility (Gregory, 1985) have been implicated. 
Alterations to physiological optimal conditions within the animal ultimately contribute to 
decreased performance. However, studies in sheep have indicated that these physiological 
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changes, specifically altered rumen pH, can act as a defense mechanism and prevent further 
establishment of parasites in a situation where an infection is already in progress and an immune 
response has not been mounted yet (Blanchard, 1985; Coop et al., 1986, 1988; Jackson, 1992,).  
Parasitic infections can also impact nutrient absorption and utilization within the host. 
The most notable nutrient impacted by parasitic infections is protein. Parasitized animals have 
increased losses of endogenous protein into the gastrointestinal tract through plasma and 
erythrocytes (Holmes et al., 1968; Bremner, 1969; Holmes, et al., 1986) as well as sloughed 
epithelial cells and increased mucous secretions (Armour et al., 1966; Coop and Angus, 1975; 
MacDonald and Ferguson, 1978; Rowe et al., 1982). While lost endogenous protein has the 
potential to be reabsorbed in the distal end of the small intestine, there may be a reduction in the 
overall protein absorption (Poppi et al., 1986). Furthermore, lost protein leaving the abomasum 
from parasitized animals is often in the form of ammonia with increased urea synthesis and is 
unrecoverable by the animal (Rowe et al., 1982; Rowe, 1988). These studies suggest that 
parasitic infections result in a reduced availability of protein as well as increase the minimum 
amino acid requirement (Rowe, 1988).  
Other nutritional impacts of parasitic infections include alterations in energy and mineral 
metabolism. Studies in both sheep and cattle have demonstrated reduced digestion of gross 
energy in diets in a range of helminth infection (Sykes and Coop, 1977; Randall and Gibbs, 
1981; MacRae et al., 1982). However, results from these studies are variable and no correlation 
has yet been found between protein and energy metabolism during a parasitic infection.  While 
limited literature exists, mineral metabolism, and thus, skeletal growth and mineralization, have 
also been found to be affected in the presence of gastrointestinal parasites. Most notably, calcium 
and phosphorus deposition have been found to be greatly reduced when compared to pair-fed 
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counterparts (Sykes and Coop, 1977; Sykes et al., 1977). When evaluating trace mineral 
metabolism, Bang et al., (1990a) demonstrated a reduction in copper uptake by the liver during a 
parasitic infection as a result of elevated abomasal pH and a reduction of solubility of 
supplemented copper. Interestingly, follow-up studies (Bang et al., 1990b) indicated that copper 
administered in the form of copper oxide wire particles, when administered prior to infection, 
can reduce the establishment of certain parasite species in treated lambs. It should be noted that 
amounts of copper administered in this study were above normally recommended values to 
ensure sustained concentrations of abomasal soluble copper. Supplementation with molybdenum 
has been studied as well. Suttle et al. (1992a, 1992b) found that supplementation reduced worm 
burdens by 23% and 78%, respectively. Results from these studies have implicated a role of 
molybdenum in immune response as well as having a direct impact on parasites. Ferguson et al. 
(1989) found higher fecal egg counts as well as increased pepsinogen levels in lambs 
experimentally infected with T. circumcincta in the presence of a cobalt deficiency. While it is 
clear that mineral metabolism can be affected by parasitic infections, more studies are necessary 
to identify key minerals and supplementation recommendations.  
 
2.7 Production responses following anthelmintic treatment 
Numerous studies have shown that large portions of beef and dairy herds are parasitized. 
Abattoir and fecal egg count studies indicate that approximately 60 – 100% of cattle of various 
classes including beef cattle, beef calves, and dairy cattle have some level of parasite burden 
(Barth et al., 1981; Bairden and Armour, 1981; Vercruysse et al., 1986; Cox and Lemiski, 1989; 
Borgsteede et al., 2000; Drake et al., 2001; Murphy et al., 2006). Even low-level, subclinical 
infection can result in the depression of a number of production parameters among all classes of 
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cattle. However, anthelmintic treatment has been shown to improve production parameters 
across all segments of the beef industry including increased weight gains, higher dry matter 
intake (DMI), improved feed efficiency, increased milk production, improved reproductive 
performance, improved carcass quality, higher (BCS), and a stronger immune system (Hawkins, 
1993; Zajac, 1991; Purvis et al., 1994; Stromberg et al., 1997; Sanchez et al., 2002; Hersom et 
al., 2011; Clark et al., 2015).  
 
2.7.1 Live performance and growth 
2.7.7.1 Cow-calf. Anthelmintics used in cow/calf production have demonstrated positive effects 
on calf growth, dam weight gain and have been implicated in improving pregnancy rates. Results 
reporting the effect of anthelmintic treatment on cow weight are variable. Ciordia et al. (1982) 
reported weight advantages of 28.8 kg for treated cows compared to non-treated controls. 
Similarly, Stuedemann et al. (1989) reported weight gain advantages for treated cows compared 
to non-treated controls. However, Ciordia et al. (1984), Bumgarner et al. (1986) and DeRouen et 
al. (2009) saw no differences or trends in maintenance of treated cows when compared to cows 
that were not treated. Interestingly, Stromberg et al. (1997) reported lower weight gains for 
treated cows as well as a greater loss of BCS at time of weaning when compared to non-treated 
controls over a two-year study. When evaluating the effect of an extended-release anthelmintic, 
Backes (2016) saw no differences in BW between non-treated cows, cows treated with a short 
duration oral oxfendazole, and cows treated with extended-release eprinomectin. Meyers (1988) 
has suggested that increased milk production and/or improved reproductive success following 
anthelmintic treatment may confound cow weights so that weights may not be a meaningful 
production parameter when studying parasite control.  
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 While cow results may vary, effect of anthelmintic treatment on calf gain are consistent 
in all trials with treated calves gaining more weight and having higher ADG than non-treated 
calves (Ciordia et al., 1982; Ciordia et al., 1987; Stuedemann et al., 1989; Wohlgemuth et al., 
1990; Stromberg et al., 1997; Forbes et al., 2002; DeRouen et al., 2009; Hersom et al., 2011). 
Ciordia et al. (1982) speculate that improved weight gains in calves may be due to either a direct 
influence of anthelmintic treatment on calf parasites or indirectly through reduced parasitism in 
cows resulting in increased milk production.  Stromberg et al. (1997) and Frechette and Lamothe 
(1981) both reported increases in milk production, which supports the latter hypothesis.  
 
2.7.1.2 Heifers. Although not always statistically significant, dewormed heifers consistently 
gained more weight, and gained more quickly, than non-dewormed, control groups (Zajac et al., 
1991; Bauck et al., 1992; Boyles et al., 1993; Larson et al., 1995; Mejita et al., 1998; Loyacano 
et al., 2002; Sanson et al., 2003). Mejita et al (1998) reported that female calves treated with 
ivermectin continuously from birth grew faster than untreated heifers and that weight differences 
were consistently significant at all time points past 6 months of age. Larson et al. (1995) noted 
that treated heifers had improved weight gain through summer grazing and pre-breeding, but not 
during the breeding season. It was also noted that most weight gained by treated heifers was 
gained in the first 28 days following anthelmintic treatment and that overall weight gain was 
correlated with an increase in BCS (Larson et al., 1995). Both Larson et al. (1995) and Mejia et 
al. (1998) noted significant increases in pelvic area of treated heifers compared to untreated 
heifers. Pelvic areas were increased by 7.5% in treated heifers (Larson et al., 1995). Pelvic areas 
were significantly increased by 8% and 11% at week 39 and 15 months of age, respectively, in 
treated heifers (Mejia et al., 1998). 
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Zajac et al. (1991) and Sanson et al. (2003) also reported consistently higher weight gains 
in treated, grazing heifers than un-treated cohorts. Boyles et al. (1993) reported faster drylot 
gains and more uniform gains during both drylot and pasture phases for treated heifers compared 
to non-treated heifers. Backes (2016) also reported greater post-weaning gains for heifers treated 
with either a short duration combination pour-on of moxidectin and oxfendazole or extended-
release eprinomectin when compared to non-treated controls.  
 
2.7.1.3 Stocker and feedlot. Benefits of deworming can be seen in both the stocker and feedlot 
sectors of the beef industry. Studies have indicated deworming not only results in higher body 
weights and ADG, but also improves carcass qualities along with reducing morbidity and 
mortality, resulting in economic benefits (Smith et al., 2000; Reinhardt et al., 2006; Clark et al., 
2013; Clark et al., 2015). 
In studies evaluating the effect of anthelmintic treatment on growth of stocker calves, 
Williams et al. (1995) saw 31 kg weight advantages for treated calves compared to un-medicated 
calves. Ballweber et al. (1997) also saw greater ADG for treated calves compared to non-treated 
calves in 3 out of 4 studies across the United States. Likewise, Skogerboe et al. (2000) saw 
greater ADG in treated stocker calves than un-medicated cohorts in three trials in three different 
states. Rickard et al. (1991) also noted advantages in ADG in grazing yearling steers 
administered ivermectin in a sustained release bolus. DeDonder et al. (2015) also saw greater end 
weight and greater ADG for stocker calves treated with extended-released eprinomectin 
compared to short duration doramectin.  
Clark et al. (2013) noted greater change in BW and ADG over the stocker period for fall-
born heifers treated with an extended release dewormer compared to a short duration dewormer. 
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However, difference in performance during the stocker phase did not translate into performance 
difference in the feedlot or difference in carcass quality.  
Smith et al. (2000) studied the effect of strategic deworming during the stocker phase 
and/or subsequent treatment at the start of the feedlot phase. Treatments consisted of: 1) no 
treatment during either pasture or feedlot phase 2) treatment only during the pasture phase 3) 
treatment only during the feedlot phase, and 4) treatment at both pasture and feedlot phase. 
During the pasture phase, treated steers gained approximately 22 kg more than control steers. 
The study concluded that a two-time treatment, once during the stocker phase and once when 
entering the feedlot, significantly affected final weight, ADG, DMI, and feed to gain (F:G) 
conversions, however, a much greater effect on these parameters was seen in calves only treated 
at the time they entered the feedlot. On a live basis, calves treated only upon entering the feedlot 
saw the largest ADG, F:G, daily DMI and HCW along with an improved dressing percentage 
compared to all other treatment groups. Animals treated either once during the stocker phase or 
at both the stocker phase and feedlot also had improvements in performance. On a carcass 
adjusted basis, calves treated once upon entering the feedlot and calves treated at both phases had 
an even greater improvement on daily gain and F:G, which is attributed to improved dressing 
percentage (Smith et al., 2000). Utley et al. (1974) also noted advantages for heifers treated at the 
start of the feedlot phase for ADG and feed efficiency compared to un-medicated controls. 
While Backes (2016) reported greater post-weaning gains in calves treated with either a 
short duration oral oxfendazole or extended-release eprinomectin compared to non-treated 
controls, there were no difference between HCW, 12th rib fat thickness, or marbling. However, 
control calves had a lower YG and a greater Longissimus muscle area although there were no 
differences in quality grade between treatments. When comparing similar anthelmintic 
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treatments, Watson (2016) saw no difference in BW or ADG of stocker calves. Vesco et al. 
(2015) saw a slight advantage in weight for heifers treated with an extended-release treatment 
compared to a conventional dewormer.   
Clark et al. (2015) observed how the level of parasites upon arrival could affect feedlot 
performance. The study found that, while anthelmintic treatment at the beginning of the feeding 
phase helped to improve production parameters in all animals, animals with higher initial 
parasite burdens saw less improvement, having lower BW throughout the feeding phase and 
requiring more days on feed. This study also noted a trend for lesser 12th-rib backfat thickness, 
LM area and marbling scores at slaughter. This data suggests that long-term damage from 
parasite burdens acquired during the grazing phase prior to entering the feedlot can impact 
feedlot performance and carcass quality.  
 
2.7.2 Health 
 While seldom reported in literature, parasite burdens can impair immune response in 
infected animals. Clark et al. (2015) noted that feedlot cattle with a lower parasite burden at the 
start of the feeding phase were treated for less health issues resulting in reduced cost of health 
treatments and increased income. Likewise, Smith et al. (2000) reported that steers not 
dewormed during the stocker phase arrived at the feedlot with a compromised 
immunocompetency status. While a limited number of feedlot trials have attempted to elucidate 
the effect of anthelmintic treatment on health parameters, no similar studies have been done in 
grazing cow/calf or stocker operations where exposure to parasites is heightened.  
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2.7.3 Reproduction 
 Anthelmintic treatment of yearling heifers has been shown to reduced age at onset of 
puberty and improve pregnancy rates (Boyles et al., 1993; Larson et al., 1995; Majia et al., 
1998). A hastening of the onset of puberty was reported by Mejia et al. (1998) with treated 
heifers reaching pubertal status, based on serum progesterone concentrations, by 36 weeks of 
age, while untreated heifers did not reach puberty until 46 weeks of age. Larson et al. (1995) also 
observed a higher percentage of treated heifers reaching puberty before untreated heifers. 
Interestingly, both previously noted studies reported non-significant correlations between weight 
gain and onset of puberty for treated heifers, indicating that gain does not fully explain the 
differences in the onset of puberty (Larson et al., 1995; Mejia et al., 1998). However, 
correlations between weight gain and onset of puberty were significant (Mejia et al., 1998) or 
higher (Larson et al., 1995) for untreated heifers. Contrarily, Boyles et al. (1993) observed 
similar onsets of puberty across treated and untreated groups. 
 Similarly, Purvis and Whittier (1996) conducted a two-year study to determine the effects 
of treatment with an ionophore, an anthelmintic, or a combination of the two would impact age at 
puberty when compared to control heifers. Because diets were adjusted regularly to achieve 
equal weights across all four treatments, there was no correlation between onset of puberty and 
weight. The authors also found an increase in first-service conception rate, although no 
differences in overall pregnancy rates were noted. The study determined that animals treated 
with an ionophore, an anthelmintic, or a combination were 10 kg lighter and 8.8 days younger at 
puberty than controls. It is noteworthy that the combination of treatments was not different than 
single treatments of either an ionophore or an anthelmintic suggesting there was no additive 
effect when the treatments were administered simultaneously.  
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Larson et al. (1995) observed a 56.4% average pregnancy rate for treated heifers 
compared to a 25.6% average pregnancy rate for untreated heifers, however higher pregnancy 
rates were not attributed to treatment, but to a higher number of treated heifers reaching attaining 
puberty before the end of the breeding season. Boyles et al. (1993) observed no difference across 
treatments of conception to AI with both groups achieving 65% conception rates. Backes (2016) 
found heifer cyclicity, estrous detection, natural service, and overall pregnancy rates were greater 
for heifers treated with either a short duration or extended-release dewormer compared to control 
heifers.  
While few studies have evaluated the effect of anthelmintic treatments on reproduction in 
mature cows, studies have found anthelmintic treatment improves reproductive performance of 
treated cows when compared to non-treated controls. Studemann et al. (1989) reported an 
average pregnancy rate of 97.5% for treated cows while untreated cows had an average 
pregnancy rate of 75%. While they reported no change in calving interval, calving rates for 
treated cows were higher with an average calving rate of 90% compared to an average rate of 
67.5% for untreated cows (Studemann et al., 1989). Correspondingly, Stromberg et al. (1997) 
found significant improvement reproductive with an 11.8% and 12.4%, respectively during a 
two-year period with an average pregnancy rate of 94.2% for treated cows and 82.1% for 
untreated cows over the two-year trial. Conversely, Backes (2016) found no differences in 
pregnancy rate between control cows, and cows treated with either a short duration oral 
oxfendazole or an extended-release eprinomectin.  
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2.8 Economics of parasitism 
 It is undisputed that GIN infections in cattle impact economics by decreasing 
animal performance via a variety of physiological mechanisms (Hawkins, 1993; Morris and 
Marsh, 1994; Perry and Randolph, 1999; Stromberg and Gasbarre, 2006; Charlier et al., 2012; 
Charlier et al., 2014). Estimations for economic losses from parasitic infection of livestock in the 
United States alone are over $3 billion annually (Bagley et al., 1998). However, due to the 
subclinical nature of many parasitic diseases, identification of economic losses is difficult 
(Vercruysse and Claerebout, 2001; Charlier et al., 2014) and therefore little data exists.   
 While decreased production parameters have been clearly demonstrated in response to 
parasitic infection, growth and production advantages following the use of deworming products 
have been established in all phases of beef production ranging from pregnancy rates through the 
feedlot phase (Zajac, 1991; Purvis et al., 1994; Stromberg et al., 1997; Sanchez et al., 2002; 
Hersom et al., 2011; Clarke et al., 2015). Eradication of parasites and parasitic diseases is 
unlikely even under the most optimal of conditions (Perry and Randolph, 1999; Le Jambre, 
2006) and parasitic infections can have long-term effects on production even after successful 
removal from their host (Perry and Randolph, 1999; van der Voort et al., 2013). Since the disease 
cannot be avoided, assessment of the economic impact of parasitic infections should focus on the 
recoverable portion of production through anthelmintic intervention (Perry and Randolph, 1999; 
van der Voort et al., 2013).  
Lawrence and Ibarburu (2007) assessed the how elimination of current pharmaceutical 
technologies would impact break-even prices in all segments of the beef industry. The study 
evaluated the value of certain pharmaceutical technologies and identified deworming as the most 
important technology available to beef producers. The authors reported that deworming in the 
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cow/calf sector greatly impacted weaning rate, which encompasses pregnancy rate and survival 
rate of calves, and weaning weight. Elimination of this technology in this sector would result in a 
$165/pair loss to producers. Likewise, removal of this technology in the stocker segment would 
result in a $21/head/year loss due to reduced ADG. Exclusion of de-worming technologies in the 
feedlot would result in a loss of $22/head/year based on reduced feed intake and ADG. Overall, 
the cost of eliminating deworming technologies in the beef industry is $190 per head annually. 
This study identified a significant impact of parasite control on production and cost to beef 
system, making its impact significant over all three segments of beef production.  
While cost-benefit analysis may be more appropriate for elucidating the economic impact 
of parasitic infections, they can be very difficult to determine (Perry and Randolph, 1999 van der 
Voort et al., 2013). Accounting for highly variable management strategies, treatment techniques, 
environmental conditions, and cost differences between farms can present challenges to 
economic analysis of parasitic diseases (Charlier et al., 2014; Charlier et al., 2016).   
 
2.9 Conclusion 
 According to the National Animal Health Monitoring System (NAHMS), 
approximately 62% of producers deworm unweaned calves, 75% deworm developing 
replacement heifers, 59% deworm weaned stocker calves, 87% treat mature cows, and 90% treat 
all classes of cattle at least occasionally (NAHMS, 2008). From the same survey, 85% of 
operations indicated that cattle were dewormed on a regular schedule regardless of appearance or 
any other diagnostic tool. Deworming is a common practice for beef producers around the 
country and can help mitigate nutritional inefficiencies and decreased performance created by 
parasitic infections. Performance improvements can clearly be demonstrated on a number of 
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parameters including calf growth, stocker calf growth, replacement heifer development, feedlot 
performance and carcass characteristics. Thus, the practice of implementing parasite control 
within a herd, or not implementing parasite control, has economic implications for producers and 
has the potential to strongly impact break-even prices, most notably in the cow/calf sector. 
However, relatively few studies have focused on its effect on mature, grazing beef cow herds, 
which is surprising considering it is the largest group of cattle to receive regular anthelmintic 
treatment. It is clear from aforementioned impacts of parasites on production parameters in 
parasitized animals that performance of grazing, reproducing, lactating cattle may be greatly 
impacted by a parasitic infection. Therefore, understanding how herd health programs, such as 
deworming strategies, may help improve reproductive performance and performance parameters 
in beef cow herds is important and can have economic implications for cow/calf producers.   
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CHAPTER 3.   
EFFECTS OF EXTENDED-RELEASE EPRINOMECTIN ON COW/CALF 
PERFORMANCE AND REPRODUCTIVE SUCCESS IN A FALL-CALVING BEEF 
HERD 
 
3.1 Abstract 
A fall-calving Angus herd was utilized to elucidate the effects of extended-release eprinomectin 
compared to a conventional deworming product on cow performance and reproductive success as 
well as performance of progeny. In Exp. 1, 119 fall-calving cows were treated with either a 
conventional, short duration injectable ivermectin (n=53; CONV) or an injectable extended-
release eprinomectin (n=66; EPR) in August 2015 prior to calving.  Cow BW were collected at 
time of treatment and at pregnancy diagnosis in April of 2016 after a 90-d natural breeding 
season. Calving data from both 2015 and 2016 calving seasons were collected. Performance and 
reproductive success of cows following treatment was evaluated. Calving interval between the 
2015 and 2016 calving season as well as calving distribution in 2016, the year following initial 
treatment, were evaluated.  Performance results were analyzed using PROC mixed of SAS and 
reproductive endpoints were analyzed using the GLIMMIX in SAS. Change in BW and average 
daily gain were greater in EPR cows compared to CONV cows (P ≤ 0.01). Pregnancy rates 
tended to be greater for EPR than CONV cows (P = 0.15). Calves from dams treated with EPR 
were younger at weaning, but had greater weaning weights than calves from CONV dams (P < 
0.01). In Exp. 2, 74 yearling fall replacement heifers were treated with a conventional, short 
duration injectable ivermectin (n=33; CONV) or an injectable extended-release eprinomectin 
(n=44; EPR) in August of 2015 and BW were taken. In December, heifers were AI if standing 
heat was observed followed by a 45-day natural breeding season. Pregnancy diagnosis was 
conducted and BW were taken in April of 2016. Final BW were collected in August of 2016. 
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Performance, cyclicity, conception to AI, and overall breeding season pregnancy rates were 
evaluated. Calving data was collected during the first calving season in the fall of 2016 to 
evaluate calving distribution. Data were analyzed in an identical manner to Exp. 1. Weights 
taken 7 months and 12-months post-treatment demonstrated heavier BW (P < 0.01; P = 0.10), 
greater overall weight gain (P ≤ 0.01) and a greater ADG (P < 0.01) for heifers treated with EPR. 
Heifers treated with EPR had greater yearling pregnancy rates to AI (P = 0.03) and greater 
overall pregnancy rates (P = 0.02) compared to CONV. Also, a greater proportion of EPR heifers 
calved in the first 21 days of the subsequent calving season (P = 0.04). Results from this study 
indicate improved performance and greater reproductive success for replacement heifers and 
mature cows treated with extended-release eprinomectin as well as performance advantages for 
their subsequent offspring compared to animals treated with ivermectin.  
 
Key words: anthelmintic, cow-calf, dewormer, pregnancy 
 
3.2 Introduction 
Parasitic infections in cattle are known to negatively impact cattle performance by depressing 
a number of production variables including weight gain, milk production, reproductive 
efficiency, and carcass quality (Hawkins, 1993). It has been demonstrated that anthelmintic 
treatment which reduces or eliminates gastrointestinal worm burdens can positively influence 
cattle productivity by improving the aforementioned parameters (Stromberg et al., 1997; Hersom 
et al., 2011; Clark et al., 2015). Anthelmintic drugs have long been used in commercial cattle 
production as a means to prevent internal parasitic infection and improve production in all 
classes of the beef industry. Specifically in cow/calf production, anthelmintic treatment has been 
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shown to improve growth, hasten onset of puberty in developing heifers and improve first 
breeding season pregnancy rates (Larson et al., 1995; Mejia et al., 1999; Loyacano et al., 2002). 
Similarly, in mature cows, anthelmintic treatment can improve or help BCS, improve overall 
breeding season pregnancy rates, and impact progeny performance (Stuedemann et al., 1989; 
Wohlgemuth et al., 1990; Stromberg et al., 1997; Hersom et al., 2011).   
In 2012, Merial, Inc. (Duluth, GA) introduced the extended-release version of their injectable 
anthelmintic drug, eprinomectin. This product label claims 100 to 150 days of parasite protection 
with one injection. Research evaluating plasma concentration of eprinomectin over the extended-
release period showed effective plasma concentrations up to 150 d post-administration (Solls et 
al., 2013). Although this anthelmintic has shown to reduce worm burdens and increase weight 
gains in stocker cattle (Rehbein et al., 2013a, 2013b; Clark et al., 2014) little research has been 
published regarding the effects of extended-release eprinomectin on reproductive performance in 
beef cows and heifers compared to a traditional, short duration anthelmintic. Therefore, the goal 
of this study was to assess performance parameters and reproductive success of fall-calving 
replacement heifers and mature cows treated with extended-release eprinomectin compared to a 
conventional, short duration injectable ivermectin. We hypothesized that treatment of cows and 
replacement heifers with extended-release eprinomectin would improve cow performance and 
reproductive success in fall-calving herds and positively impact progeny performance compared 
to a short duration, conventional anthelmintic. 
 
3.3 Materials and Methods 
Data were collected under the supervision of trained Merial personnel and all procedures 
and protocols were in compliance with Merial Institutional Care and Use Committee approvals.  
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In both experiments, all treatments were administered subcutaneously at 1 ml/50 kg of 
BW. Needles on the treatment syringes were changed as needed to ensure proper delivery of the 
product. Observation of cattle following treatment indicated no abscesses at the injection site.     
 
3.3.1 Experiment 1  
A herd of 119 fall-calving Angus cows were managed in two groups separated by age (first-
calf heifers [n = 38]; and ≥ 3 years of age [n = 81]) at a cooperator farm in northwest Missouri. 
Each age group was managed on a singular, but separate pasture. In August of 2015, before 
calving season, cows were individually weighed and assigned to either: 1) injectable ivermectin 
(Vetrimec™; VetOne, Boise, Idaho; n=53 [n = 19 primiparous; n = 34 multiparous cows]; 
CONV) or 2) injectable extended-release eprinomectin (LongRange™; Merial, Duluth, GA; n = 
66 [n = 18 primiparous; n = 47 multiparous]; EPR; Figure 1). Cows were randomly allocated to 
treatment within age group, thus both treatments were represented in each pasture. Following 
treatment in August, a 76-day calving season began in early September and continued through 
late November (Figure 1).  Breeding was accomplished using non-synchronized natural service 
with two herd sires for the first calf heifers and three herd sires for the mature cows. The 90-d 
breeding season began in late November of 2015. In April of 2016, all cows were weighed and 
palpated to determine overall breeding season pregnancy rates.  
Animals continued to be managed by age on separate pastures and were monitored through 
the subsequent calving season. Dam BW, performance, overall pregnancy rates, calving interval 
between 2015 and 2016 calving seasons, as well as performance data from the 2015 calf crop 
were evaluated. Because animals were randomly assigned to treatment and not stratified by 
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initial BW, treatment effects on performance were primarily evaluated based on change in BW 
and ADG.  
 
3.3.2 Experiment 2 
In August of 2015, before to their first breeding season, a herd of 74 fall-calving replacement 
heifers at a cooperator farm in northwest Missouri were allocated to one of two anthelmintic 
treatments. Heifers were individually weighed and treated with either an injectable ivermectin 
(Vetrimec™, VetOne, Boise, Idaho; n=33; CONV) or injectable extended-release eprinomectin 
(LongRange™, Merial, Duluth, GA; n = 41; EPR) before initiation of their first breeding season 
(Figure 2).  
Following treatment, groups were kept on separate- but like-pastures (one treatment per 
pasture; 2 total pastures). In December, all yearling heifers were monitored for estrus over a 25-
day period and artificially inseminated if a standing heat was observed. Following this period, all 
heifers were exposed to a bull for a 47-day natural service breeding season with two herd sires 
turned out with each group. Forty-five days after the bulls were removed, heifers were 
individually weighed and evaluated for both pregnancy to AI and overall breeding season 
pregnancy rates. 
In August 2016, heifers were individually weighed, and all animals were dewormed with 
injectable extended-release eprinomectin prior to their first calving season. Body weights, ADG, 
AI pregnancy rates, overall pregnancy rates, and calving distribution were evaluated.  
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3.3.3 Statistical Analysis 
3.3.3.1 Experiment 1. For all analyses, SAS 9.4 (SAS Institute, Inc., Cary, NC) was 
utilized with an experimental unit of cow or calf, when appropriate, and a fixed effect of 
treatment. Cow performance variables also included a fixed effect of age and a covariate of BW 
at treatment to account for differences in initial weight. The main effects of treatment and age 
(primiparous or multiparous) were tested as well as the appropriate interaction.  The interaction 
was removed if not significant (P > 0.10). Performance data were analyzed using the MIXED 
procedure of SAS. Pregnancy data, calving interval and calving distribution were analyzed using 
GLIMMIX of SAS. A first-calf heifer in the EPR group died during the calving season to issues 
unrelated to treatment and was removed from analysis (final number of experimental units: 
CONV n=53; EPR n = 65). For calf data calf sex, was utilized as a main effect when analyzing 
weaning weights.  
3.3.3.2 Experiment 2. For analyses, SAS 9.4 was utilized with an experimental unit of 
heifer and a fixed effect of treatment. Performance data were analyzed using the MIXED 
procedure. Pregnancy data, calving interval and calving distribution were analyzed using 
GLIMMIX in SAS. 
For all analysis, significance was declared at P ≤ 0.05 and tendencies 0.05 ˂ P ≤ 0.15. 
 
3.4 Results and Discussion 
3.4.1 Experiment 1 
Dam performance results and reproductive measurements are reported in Table 1. There was 
a treatment × age interaction for treatment BW (P ≤ 0.01; Figure 3). Specifically, multiparous 
EPR dams were significantly heavier at treatment (P < 0.001) than primiparous cows and 
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multiparous CONV dams. Furthermore, multiparous CONV cows were heavier than primiparous 
cows. This initial weight difference did translate to significant weight differences at time of 
pregnancy checks where multiparous EPR cows were heavier compared to the other treatment 
groups, although there was no treatment × age interaction. This is a reflection of study design as 
animals were randomly allocated to treatment and were not stratified by weight, age, parity, or 
expected calving date. There was a treatment × age interaction for ADG and change in BW. In 
multiparous cows, EPR lost less BW and had a higher ADG over the course of the grazing 
season, whereas no differences in weight loss were observed due to treatment in primiparous 
females. 
Cows treated with EPR tended to have greater overall pregnancy rates (P = 0.10; Table 1) 
than CONV (P = 0.15; Table 1), which could result in significant economic impact at the 
producer level. Although not comparable to the present study, previous literature has shown 
greater pregnancy rates for cows given anthelmintic treatment than cows not given anthelmintic 
treatment (Stuedemann et al., 1989; Stromberg et al., 1997). The studies of Studemann et al., 
(1989) and Stromberg et al (1997) compared non-treated controls to those administered 
anthelmintic treatment, whereas the current study compares two anthelmintic treatments with 
different lengths of protection. The extended protection against gastrointestinal parasites claimed 
by EPR (100 – 150 d; Solls et al., 2013) compared to CONV (14 – 28 d) may have allowed for 
re-infection of CONV while EPR were not re-infected again over the grazing season. This 
extended protection appears to have led to differences in performance and may have impacted 
reproductive success. It is plausible that improved ability of EPR cows to maintain BW during 
early lactation for an extended period over the course of the grazing season, may have 
contributed to reproductive success (Short et al., 1990; Hess et al., 2005).  It is well known that 
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energy is crucial to beef cow reproduction (Hess et al., 2005). Therefore, maintaining BW and 
BCS during this nutritionally demanding stage of production, may have maintained or increased 
energy balance, and may have positively influence reproductive performance (Hess et al., 2005) 
Furthermore, cows treated with EPR had a 10 d shorter calving interval than CONV (P = 
0.03; Table 1). A shorter calving interval may provide economic benefits through both increased 
calf weaning weight and increased post-partum recovery before initiation of the breeding season 
and is negatively correlated with nutritional status of the animal (Bridges and Lemenager, 2007).  
Calf performance for the 2015 calf crop are reported in Table 2. Calves from EPR dams were 
younger at weaning (P = 0.007), tended to have a greater actual weaning weight (P = 0.09), and 
thus had greater age-adjusted weaning weights (P < 0.001) when compared to calves from 
CONV dams. As expected, calves from older cows had greater weaning weights (P < 0.001; data 
not shown) when compared to first-calf heifers although there was no treatment × age interaction 
(P = 0.84). Increased performance in pre-weaned calves following anthelmintic administration 
could be a result of direct action of anthelmintic treatment on the calf parasites (Ciordia et al., 
1982). However, calves in this study were not directly dewormed. Based on previous studies, we 
may infer that by treating dams and reducing parasite load on the pastures, calves were indirectly 
protected through dam treatment, thus improving calf performance. A corresponding increase in 
cow milk production following dam anthelmintic treatment could also result in improvements in 
calf growth (Ciordia et al., 1982). Previous studies have reported increased milk production 
(Frechette and Lamothe, 1981; Stromberg and Corwin, 1993), providing support to this 
hypothesis.  It is possible that better maintenance of BW for EPR cows may have increased milk 
production compared to CONV cows and thus calf weaning weights, although milk production 
was not directly measured in the present study. Furthermore, because cows were treated during 
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the last trimester, an improved nutritional status of the EPR dam during crucial points of fetal 
development following treatment may have positively impacted both pre- and post-natal 
development and productivity (Wu et al., 2004). 
 
3.4.2 Experiment 2 
Performance results for Exp. 2 are reported in Table 3.  Initial BW did not differ between 
groups (P = 0.98). However, EPR heifers were heavier at spring pregnancy evaluation (P < 
0.001) than CONV and tended to weigh more a year after initial treatment (P = 0.10) than 
CONV. Moreover, when compared to CONV, EPR also had a greater overall change in BW and 
higher ADG (P < 0.001) from the time of initial treatment to the time of pregnancy evaluation 
the following spring. Similarly, Backes (2016) found that EPR treated fall replacement heifers 
were heavier and grew faster than cohorts treated with a combination of pour-on moxidectin and 
oral oxfendazole.  
During the 25-day AI period where animals were monitored for estrus prior to bull turn-out, 
there was no difference in the number of CONV or EPR heifers noted cycling (P = 0.31; Table 
4).  However, conception to AI (P = 0.03; Table 4) and overall breeding season pregnancy rates 
(P = 0.03) were greater for EPR compared to CONV. These results agree with Backes (2016) 
who noted no difference in cyclicity at the start of the grazing season between treatment groups, 
but saw greater conception rates for heifers treated with extended-release eprinomectin compared 
to heifers treated with combination of pour-on moxidectin and oral oxfendazole. In the year 
following treatment, EPR heifers in the current study began calving 10 days sooner and had an 
average Julian calving date that was 12 days earlier (P = 0.06) than CONV. Moreover, EPR had 
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a larger percentage of calves born in the first 21 days of the calving season compared to CONV 
(17% CONV; 44% EPR; P = 0.04).  
Data from the US Meat Animal Research Center have illustrated that heifers that breed 
earlier in the breeding season and calve earlier the subsequent year have greater reproductive 
success in their second breeding season, wean heavier calves, and have greater longevity in the 
herd (Kill et al., 2012). Although more validation is needed, these data implicate economically-
relevant immediate and long-term production advantages for fall-bred heifers treated with 
extended-release eprinomectin compared to a conventional ivermectin injectable dewormer.   
 
3.5 Implications 
It is important to acknowledge that because fecal samples were not collected in this trial, 
little is known about the level of parasitic infection of these cattle, therefore, caution should be 
taken when extrapolating these data to larger populations or alternative environments. However, 
the results of this study indicate that treatment with extended-release eprinomectin may result in 
performance and reproductive advantages for both replacement heifers and mature cows when 
compared to a conventional, short duration injectable ivermectin. Dam treatment with extended-
release eprinomectin may also have an indirect impact on growth and performance of their 
offspring. 
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Figure 1: Experimental timeline for Exp. 1. 
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Figure 2: Experimental timeline for Exp. 2. 
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Table 1: Performance of fall-calving cows treated with different anthelmintic treatments during the grazing season (Exp. 1). 
1Treatment: CONV = ivermectin (Vetrimec 1%; VetOne, Boise, Idaho; n = 53); EPR = extended release eprinomectin (LongRange; 
Merial, Duluth, GA; n = 65). 
2Age: primiparous (n = 38); multiparous (n = 81). 
3P-value: Significant P ≤ 0.05; Tendency 0.05 < P ≤ 0.10. 
4Larger SEM presented. 
5Calculations based on weight changes from August 2015 to April 2016. 
6Pregnancy rate for 2016; natural service only; only one pregnancy diagnosis. 
7Calving interval from 2015 calving to 2016 calving. 
 
 
 
 
 
 
 
 Treatment   
 CONV1 EPR1  P-Value3 
Item 
Primiparous
2           
Multiparous
2 Primiparous
2          
Multiparous
2 SEM
4 
Treatment Age Treatment × Age 
Body weight, kg         
   Treatment, August 2015 487 521 481 569 10.8 0.02 <0.01 <0.01 
   Pregnancy diagnosis, April 2016 432 446 433 483 15.2 0.04 0.04 NS 
Body weight change5         
   Total, kg -91 -82 -88 -42 9.9 0.01 <0.01 0.02 
   Percent change, % -17.7 -15.2 -16.7 -8.0 2.0 0.01 <0.01 0.05 
   ADG, kg -0.35 -0.33 -0.34 -0.17 0.04 <0.01 0.01 0.02 
Reproduction         
   Pregnancy rate6, % (no./no.) 89.5 (17/19) 88.2 (30/34) 94.4 (17/18) 97.9(46/47) --- 0.15 0.82 NS 
   Calving interval7, days 376 365 365 355 5.9 0.03 0.05 NS 
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Table 2: Performance of fall calves whose dams were treated with different anthelmintic 
treatments during the grazing season (Exp. 1). 
 Treatment1   
Item CONV EPR SEM2 P-Value3 
Weaning weight4, kg, actual 223 235 5.1 0.09 
Weaning weight5 kg, adjusted 217 238 4.6 <0.001 
Age at weaning, days 235 229 1.8 0.007 
1Treatment: CONV = ivermectin (Vetrimec 1%; VetOne, Boise, Idaho); EPR = extended release 
eprinomectin (LongRange; Merial, Duluth, GA). 
2Larger SEM presented (n = 53 CONV; n = 66 EPR). 
3P-value: Significant P ≤ 0.05; Tendency 0.05 < P ≤ 0.10. 
4Actual weaning weight. 
5Adjusted statistically for age difference at weaning. 
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Table 3: Performance of fall-calving replacement heifers treated with different anthelmintic 
treatments during their yearling grazing season (Exp. 2).  
 Treatment1   
Item CONV EPR SEM2 P-Value3 
Body weight, kg     
   Treatment, August 2015 274 274 5.0 0.98 
   Pregnancy diagnosis, April 2016 349 374 5.2 <0.001 
   Deworming, August 2016 429 442 5.8 0.10 
Body weight change4     
   Total, kg 75 102 5.0 <0.001 
   Percent change 27.9 38.8 3.13 0.01 
   ADG, kg 0.30 0.41 0.02 <0.001 
1Treatment: CONV = ivermectin (Vetrimec 1%; VetOne, Boise, Idaho); EPR = extended release 
eprinomectin (LongRange; Merial, Duluth, GA). 
2Larger SEM presented (n = 33 CONV; n = 41 EPR). 
3P-value: Significant P ≤ 0.05; Tendency 0.05 < P ≤ 0.10. 
4Calculations based on weight changes from August 2015 to April 2016. 
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Table 4: Reproductive success of fall-calving replacement heifers treated with different 
anthelmintic treatments during their yearling grazing season (Exp. 2).  
 Treatment1   
Item CONV EPR SEM2 P-Value3 
Reproductive Success, % (no./no)     
   Cyclicity, % (no./no.) 52 (17/33) 63 (26/41) --- 0.31 
   Artificial insemination 47 (8/17) 77 (20/26) --- 0.03 
   Entire breeding season 73 (24/33) 95 (39/41) --- 0.02 
Average calving date, Julian 285 273 4.8 0.06 
Cumulative calving distribution,4 %     
   21 days 16.7 44.4 --- 0.04 
   42 days 58.3 72.2 --- 0.27 
   63 days 79.2 86.1 --- 0.48 
   84 days 100 100 --- 0.99 
1Treatment: CONV = ivermectin (Vetrimec 1%; VetOne, Boise, Idaho); EPR = extended release 
eprinomectin (LongRange; Merial, Duluth, GA). 
2Larger SEM presented (n = 33 CONV; n = 41 EPR). 
3P-value: Significant P ≤ 0.05; Tendency 0.05 < P ≤ 0.10. 
4Of heifers that became pregnant in 2015, cumulative proportion of total that calved by the end 
of each 21-d period during the 2016 calving season.  
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CHAPTER 4.  
EFFECTS OF EXTENDED-RELEASE EPRINOMECTIN ON PRODUCTIVITY 
MEASURES IN COW/CALF SYSTEMS AND SUBSEQUENT FEEDLOT 
PERFORMANCE AND CARCASS CHARACTERISTICS OF PROGENY 
 
4.1 Abstract 
The objective of this study was to elucidate the effects of a single injection of extended-release 
eprinomectin on economically relevant production variables in beef cows and calves as well as 
subsequent feedlot health, performance and carcass traits of calves. Animals from 13 cooperator 
herds across 7 states were stratified within herd by cow age, calf birth date, calf birth BW, and 
calf sex and assigned to 1 of 2 treatments; injectable doramectin (DOR; Dectomax™, Zoetis, 
Animal Health, Parsippany, NJ; n=828) or injectable eprinomection (EPR; Longrange™, Merial, 
Duluth, GA; n=832) at a rate of 1cc/50 kg. Average duration between treatment and the end of 
the grazing season was 133 ± 36 d. Fecal samples were randomly collected from 20 cows from 
five cooperator herds and consisted of both spring- and fall-calving herds. Fecal samples were 
collected at treatment and again at the end of the grazing season to evaluate fecal egg count 
(FEC). Continuous and categorical data were analyzed using the MIXED and GLIMMIX 
procedures of SAS, respectively. Cow treatment BW and end of grazing season BW were not 
different (P=0.40) between treatments. There was also no difference in change in BW or ADG 
over the course of the grazing season (P ≥ 0.12). Initial and final BCS did not differ between 
treatments (P=0.76). While FEC at treatment did not differ (DOR=2.07; EPR=2.97; P=0.18), 
cows treated with EPR had a lesser FEC at the end of the treatment period (DOR=1.76; 
EPR=0.71; P=0.02) and had a greater reduction of FEC over the course of the grazing season (P 
= 0.01). Calf treatment BW, weaning BW, and ADG did not differ between treatments (P ≥ 
0.34). There was no difference in incidence of pinkeye for calves (P = 0.43). Incidence of 
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pinkeye tended to be less (P = 0.06) for cows treated with EPR. Fly counts were not different 
between treatments (P = 0.14). Conception to AI, overall breeding season pregnancy rates, and 
calving interval were not different between treatments (P ≥ 0.45). Following weaning, a subset 
of calves from each herd selected at the discretion of the cooperator were shipped to TCSCF 
feedlot for the finishing phase. Calf BW did not differ at initiation of the feedlot phase (P = 
0.20). While EPR calves tended to be heavier at re-implantation (P = 0.07) final BW as well as 
overall ADG were not different between treatments (P ≥ 0.13). Health records indicated lower 
morbidity for EPR calves (P = 0.05) resulting in lower health costs during the feeding phase. 
Carcass performance including HCW, dressing percent, backfat, KPH, REA, YG, and marbling 
score were not different between treatment groups (P ≥ 0.12). Analysis of quality grade indicated 
higher average quality grade for EPR calves (P < 0.01) as well higher percentage of calves that 
graded average choice or higher (P = 0.03). There were no differences in the percentage of steers 
that graded low choice or lower (P ≥ 0.37). Economic analysis indicates an opportunity for 
producers working on a retained ownership platform who treated with EPR to realize a profit 
above the initial cost of treatment through improved health status during the feeding phase. A 
lack of performance differences observed in the current study may likely be a function of low 
initial fecal egg counts in participating herds.  
 
Keywords: anthelmintic, deworm, economics, fecal egg count, feedlot, pregnancy  
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4.2 Introduction 
 It has been well documented that gastrointestinal parasites can be detrimental to cattle 
health and performance. Production parameters impacted by parasitic infection include weight 
gain, reproductive efficiency, health, feedlot performance, and carcass quality (Hawkins, 1993). 
Since the 1960’s, anthelmintic treatment has been a staple in ruminant production systems to 
mitigate production losses caused by helminth infection. In cow-calf production, anthelmintic 
treatment has been shown to improve cow BW and BCS, increase overall breeding season 
pregnancy rates, and improve calf performance (Stuedemann et al., 1989; Wohlgemuth et al., 
1990; Stromberg et al., 1997; Hersom et al., 2011). The effects of anthelmintic treatment during 
the feeding phase have been shown to improvements in ADG, feed to gain (F:G), daily dry 
matter intake (DMI), and final BW (Smith et al., 2000). Furthermore, studies have linked 
calfhood deworming treatment to improved lifetime performance including growth, 
reproduction, and health (Mejia et al., 1999; Stacey et al., 1999; Clark et al., 2015).  
 In 2012, Merial, Inc. released the extended-release version of their injectable anthelmintic 
drug, eprinomectin. This product label claims 100-150 days of parasite protection with one 
injection. Evaluation of concentration of eprinomectin shows effective plasma concentrations up 
to 150 days post-administration (Solls et al., 2013). Studies with stocker cattle have proven 
extended-release eprinomectin effectively reduces worm burdens and improves weight gains in 
this class of cattle (Rehbein et al., 2013a; Rehben et al., 2013b, Clark et al., 2014). However, to 
date, little research has been published regarding the effects of extended-release eprinomectin on 
cow-calf performance. Therefore, the objective of this study was to assess economically relevant 
performance parameters in cow herds following administration of extended-release eprinomectin 
at the start of the grazing season and to assess subsequent feedlot performance of progeny. We 
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hypothesized that treatment of cows and calves with extended-release eprinomectin would 
improve cow performance and reproductive success and positively impact progeny performance 
compared to a short-duration anthelmintic.    
 
4.3 Materials and Methods 
All procedures and protocols were approved by the Iowa State University Institutional 
Animal Care and Use Committee (3-16-8209-B). 
 
4.3.1 Survey 
Because one of the study goals was to follow progeny through the feedlot phase to assess 
health and performance, Tri-County Steer Carcass Futurity (TCSCF) cooperators were identified 
as cooperators for this study because of the retained ownership platform (Reinhardt et al., 2009).  
In May 2015, a Qualtrics survey (Qualtrics, Provo, UT) was administered by TCSCF and 
Iowa State University to screen potential cooperator herds. Survey questions were aimed at 
identifying management styles, record keeping, and herd health protocols. Questions inquired 
about current parasite control programs including if a parasite control program was in place, 
what type of wormer was used (i.e. pour-on or injectable), which classes of cattle were 
commonly dewormed in the operation (i.e. cows, calves or both), and post-weaning parasite 
management of calves. Other questions identified common production practices such as if and 
when body weights were typically recorded, if and when body condition scores (BCS) were 
recorded, when calving season typically began and ended, if calving data were recorded, and if 
pregnancy checks were conducted.  
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In order to qualify for participation in the study, producers must have had a parasite control 
program in place as part of a herd health protocol and be able to provide accurate visual ID 
records for both cows and calves. Birth records, including birth date, sex, and birth weight, for 
both the year of initial treatment (2016) and the subsequent calving season (2017) must have 
been available. Producers must have had the ability to collect timely and accurate measurements 
including cow and calf BW and cow BCS at time of treatment and at weaning. Necessary 
reproduction data included pregnancy checks for both spring- and fall-calving herds with fetal 
aging if possible, AI dates (if applicable) as well as length of bull exposure. Producers that met 
minimum requirements (Table 1) were then selected for participation in the study. It is important 
to note that producers participating in this study were not required to have any history of 
parasitic infection within their herd nor were they required to identify the level of parasitic 
infection prior to the initiation of the study. 
 
4.3.2 Experimental Design 
Twelve cooperator herds located in seven states (Iowa, Missouri, Indiana, Kentucky, 
Tennessee, Ohio, and Georgia) participated in the study. The total number of animals enrolled in 
the trial was 1,768 cow-calf pairs and included both spring- and fall-calving herds. Animals were 
stratified within herd by cow age, calf birth date, calf birth BW, and calf sex and assigned to 1 of 
2 treatments; injectable doramectin (DOR; Dectomax™, Zoetis, Animal Health, Parsippany, NJ; 
n=879) or injectable eprinomection (EPR; LongRange™, Merial, Duluth, GA; n=889) at a rate 
of 1cc/50 kg. Treatments were administered in the spring of 2016 during pasture turnout (Table 
2). Average pasture turn-out date for participating herds was May 16, 2016. On average, 
treatments were administered on May 9th, 2016 with a treatment range of March 23rd to June 15th. 
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Individual and overall herd characteristics at time of treatment are presented in Table 2. Overall, 
at treatment administration, cows averaged 5 ± 3.0 years of age, weighed 568 ± 92 kg with an 
average BCS of 5.4 ± 0.9, and were 69 ± 33 days post-partum (DPP). One hundred and eight 
pairs (n = 51 DOR; n = 57 EPR) were removed from the trial due to nontreatment-related issues 
including mortality, morbidity, or culling during the grazing season.   
The study consisted of two different treatment tiers. In tier one, only cows were treated. 
Following treatment, EPR cows were managed on similar but separate pastures from DOR cows 
and treatments were not co-mingled at any time between treatment and weaning. Moreover, 
cows were not grazed in pastures where the opposite treatment had grazed previously during the 
grazing season. In tier two, EPR cows and DOR cows were co-mingled from the start of the trial. 
At approximately 90 days of age, per label instructions, calves were treated with the identical 
product as their dams. The two-tier design implemented in this study allowed for unique 
evaluation of both parasite burden and performance response. In order to maintain separate 
parasite burdens relative to treatment, tier one was implemented. This design prevents EPR cows 
from potentially diminishing parasite loads that DOR may otherwise have been exposed to. 
However, because reproductive variables were of interest in this study, tier two was implemented 
in order to evenly apply variables, such as natural service sires, between treatment groups. In 
addition, tier two allowed for mitigation of forage type and quality variables that often confound 
results in replicated grazing studies. It is important to note that previous studies have 
successfully detected performance and parasite load differences between anthelmintic treatments 
that were comingled in a grazing environment (Clark et al., 2013; Watson, 2016). 
 
 
63 
 
4.3.3 Production Measures 
4.3.3.1 Performance. Cow body weights (BW) and body condition scores (BCS; 1–9; Wagner et 
al., 1988) were taken at time of treatment and again at the end of the trial. The end of the trial 
was determined as time of weaning for spring-calving herds and at that time cows were removed 
from pasture for fall-calving herds. Calves that were in tier two of the trial were weighed at time 
of treatment (n=543 DOR; n=543). All calves in the study were weighed at time of weaning 
(n=807 DOR; n=809 EPR). Birth weights of fall calves (n=79 DOR; 73 EPR) were evaluated as 
a response variable to anthelmintic treatment. It is well established that nutritional status during 
gestation plays a crucial role in fetal development and postnatal progeny performance. 
Undernutrition, such as often seen during a parasitic infection, can be detrimental to 
development and lifetime performance of an animal by decreasing birth weight, impacting 
development during gestation, and ultimately altering post-natal metabolism and performance 
(Funston et al., 2009; Canton and Hess, 2010). 
 
 
4.3.3.2 Fecal Samples. Fecal samples were taken from a subset of five herds. Approximately 15 
cows per treatment at each location were sampled at the start (n=75 DOR; n=69 EPR) and end 
(n=70 DOR; n=65 EPR) of the trial to measure initial and final fecal egg counts. Samples 
collected included both spring- and fall-calving herds as well as herds from both experimental 
tiers. All fecal samples were shipped to Texas A&M Diagnostic Lab for analysis of fecal egg 
counts (FEC) as well as coproculture if warranted. 
 
64 
 
4.3.3.3 Health Outcomes. Available herd health records were used to analyze incidence of 
pinkeye over the course of the grazing season. Health records were submitted from two herds 
and both indicated treatment records for pinkeye for cows (n=323 DOR; n=325 EPR) and calves 
(n=312 DOR; n=308 EPR). In July, fly counts were conducted on a subset of five herds to 
evaluate fly burden. Herds included in the analysis consisted of both experimental tiers as well as 
both spring- and fall-calving herds. Live fly counts were evaluated in the pastures (n=151 DOR; 
150 EPR) in mid-July. Within a pasture, animals were selected at random and fly burdens were 
estimated from a single side of the animal and included face, shoulders, back, and legs. Flies 
were counted individually until the number exceeded 25, and then counted in groups of 5 
(Steelman et al., 1997). Estimations from a single side were then doubled to obtain a full body 
estimate of fly burden. At the time of live evaluation, pictures (n=133 DOR; n=134 EPR) were 
taken of the side used in the live analysis for fly count confirmation.   
 
4.3.3.4 Reproduction End Points. For all herds, overall breeding season pregnancy rates were 
collected for both spring and fall herds (n=828 DOR; n=832 EPR). Of participating herds, six 
producers implemented AI protocol. Where applicable, conception rates to AI were analyzed 
(n=334 DOR; n=327 EPR). Calving distribution for the 2017 calving season was evaluated as 
well as calving interval between 2016 and 2017 calving for all spring-calving herds (n=610 
DOR; n=611 EPR). 
 
4.3.3.5 Feedlot and Carcass Data. After weaning, calves were managed at individual 
cooperating locations per the standard operating procedure of each farm. A subset of calves from 
each herd at the discretion of the cooperator were then sent to a TCSCF feedlot for the finishing 
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phase. Calves arrived at the feedlot between October 16 and December 22, 2016 (n=238 DOR; 
n=259 EPR). While at TCSCF, feedlot performance and health were monitored. Finished cattle 
were harvested between March 21 and July 6 of 2017. Following slaughter, carcass data were 
collected. Thus, feedlot performance, morbidity, and carcass parameters were analyzed. 
 
4.3.3.6 Economic Analysis 
Extended-release eprinomectin (EPR) is marketed as offering novel performance 
response and has a label-claim for lengthened protection. However, the cost of this product is in 
an added out-of-pocket expense to producers compared to conventional parasite control products. 
Therefore, an economic analysis evaluating production responses to anthelmintic treatment and 
thus, economic impact on producers, was conducted. The goal of this analysis was to evaluate 
the initial cost of treatment and the differential performance needed for producers to make-up the 
increased cost of EPR compared to a conventional parasite control product like DOR. 
The economic model used for the cow-calf enterprise analysis was a partial budget 
(Texas Cooperative Extension, 2002). For this analysis, a treatment herd was standardized to 100 
cow-calf pairs. Margin over cost was set at 0% to determine breakeven prices and labor was 
considered equal between the two treatment groups. A standard weaned calf percentage of 90% 
was used for both treatments. An average weaning weight of 238 kg, was used for both 
treatments. In addition to the baseline analysis, alternative scenarios were analyzed by increasing 
or decreasing calf prices by 20% while holding all other variables constant. 
An enterprise budget was used for analysis of the feedlot data (Ag Decision Maker, 
2017). Budgets for each treatment group were created using actual records and prices reported by 
TCSCF.  
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4.3.4 Statistical Analysis 
4.3.4.1 Cow/calf analysis. Performance data and calving interval were analyzed using the 
MIXED procedure of SAS 9.4. Conception to AI, overall breeding season pregnancy rates, 
calving distribution, and health outcomes were analyzed using the GLIMMIX procedure of SAS 
9.4. Cow, or calf when appropriate, was the experimental unit for the analysis. The model 
included fixed effects of treatment, calf sex when appropriate, and included the random effect of 
pasture nested within location to account for variation within and across herds relative to 
management and weather.  
 
4.3.4.2 Feedlot performance and carcass quality analysis. Feedlot and carcass performance 
were analyzed using the MIXED procedure of SAS 9.4. Quality grade distribution and morbidity 
was analyzed using the GLIMMIX procedure of SAS 9.4. Calf was the experimental unit for the 
analysis. The model included fixed effect of treatment, a covariate of calf sex, and included the 
random effect of producer to account for variation in management. 
Tier and season were tested as main effects for interaction and removed if no interaction 
was detected. Significance was declared at P ≤ 0.05 and tendencies 0.05 ˂ P ≤ 0.10.  
 
4.4 RESULTS AND DISCUSSION 
The objective of the study was to measure a multitude of standard, economically relevant 
production variables of beef cows and calves as well as subsequent feedlot health, performance, 
and carcass traits of those calves from herds that were administered extended-release 
eprinomectin compared to dectomax 1% injectable at the labeled dose rate. 
.  
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4.4.1 Cow Performance 
Cow performance data is presented in Table 3. Initial and final BW did not differ due to 
treatment (P ≥ 0.32). In addition, change in BW over the course of the trial was not different and 
there was no difference in change in BW as a percent of initial BW which correlated into no 
differences in ADG (P ≥ 0.12). Subsequently, there were no differences in either initial or final 
BCS (P ≥ 0.23) as a result of treatment. While previous literature has found weight differences 
(Ciordia et al. 1982 and Stuedemann et al. 1989), comparisons have predominately been made 
between dewormed groups and non-treated controls. However, the present study compares 
differences between two groups treated with anthelmintics that differ in duration of efficacy. 
Results from a similar study (Backes et al., 2016) have reached comparable conclusions showing 
no overall weight difference between groups treated with a conventional short duration oral 
oxfendazole or extended-release eprinomectin. However, Meyers (1988) has suggested that 
increased performance in the form of improved milk production or reproductive success 
following anthelmintic treatment may confound cow weights so that weights may not be a 
meaningful production parameter when studying parasite control in cow-calf production.   
 
4.4.2 Health Outcomes 
Previous studies have indicated some level of fly control associated with treatment with 
extended-release eprinomectin in grazing environments (Vesco et al., 2015; Trehal et al., 2017). 
Anecdotal evidence has found reduced fly burdens with lower incidence of pinkeye in grazing 
cattle that were treated with extended-release eprinomectin. While extended-release 
eprinomectin is not labeled for fly control, one of the objectives of the current study was to 
evaluate claims of reduced fly burden and incidence of pinkeye. An evaluation of fly burden in 
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the current study indicated no differences between EPR and DOR treated cows (P ≥ 0.62; Table 
4). These results are similar to those reported by Watson (2016), where there were no differences 
in fly counts between control, combination treatment of oxfendazole and moxidectin, or 
extended-release eprinomectin treated calves comingled during a 100-day stocker period. 
Interestingly, EPR cows in the current study tended to have a lower incidence of pinkeye as 
reported by treatment records (P = 0.06), however, this reduction is not explained by differences 
in fly burden. When evaluating incidence of pinkeye in calves, there was no difference in 
pinkeye treatment between treatment groups (P = 0.43).  
There has been speculation that the fly control associated with extended-release 
eprinomectin is correlated with the reduction in pinkeye within treated herds. Fly control 
following treatment with extended-release eprinomectin is believed to be a result of residue in 
manure pats that disrupt egg and larval development of fly species who use the manure to 
procreate, in a manner similar to an insect-growth regulator (IGR). While treatment with 
extended-release eprinomectin has been shown to reduce horn fly burdens in grazing stocker 
cattle (Trehal et al., 2017), there is no data on its effectiveness on face flies, the main transmitters 
of pinkeye within a grazing herd. Furthermore, face flies can travel long distances and spend 
minimal time on an animal, making control of these pests difficult with products such as IGR 
(Antonelli and Ramsay, 2014). Therefore, it is hard to identify a causal relationship between fly 
control and pinkeye with this product. More research is necessary to verify and determine the 
relationship, if one exists, between these two variables.     
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4.4.3 Reproduction 
Marked improvement in reproductive success of both mature cow herds and developing 
heifers have been noted following administration of anthelmintic treatment when compared to 
non-treated controls (Stuedemann et al., 1989; Larson et al., 1995; Stromberg et al., 1997; 
Loyacano et al., 2002; Andresen et al., 2017). Improved conception rates that have been 
previously reported have frequently been in conjunction with increases in BW and BCS 
indicating an improvement in the nutritional status of the animal. Given the low priority of 
function of reproductive processes such as cyclicity and initiation of pregnancy (Short and 
Adams, 1988), it is plausible that the improved nutritional status often associated with 
anthelmintic treatment could improve reproductive function, especially during early lactation 
when nutritional demands are increased. The extended days of parasite protection claimed by 
extended-release eprinomectin allows the possibility to improve nutritional status for a longer 
period before reinfection with GIN during a critical time when a cow is nursing and trying to 
conceive. When evaluating reproductive success of cow herds in the current study (Table 4), 
there were no difference in conception to AI (DOR = 47%; EPR = 50%; P = 0.51) or overall 
breeding season pregnancy rates (DOR = 88%; EPR = 88%; P = 0.45). Contrarily, Backes 
(2016) reported dams treated with oral oxfendazole tended to have higher overall conception 
rates when compared to cows treated with EPR. However, neither the current study nor Backes 
(2016) reported differences in ADG or BW over the course of the grazing season, indicating 
nutritional status was not greatly improved between the short duration group and the extended 
protection groups in these studies. Evaluation of calving distribution in the calving season 
following treatment indicated no differences in the number of calves born in the first 21 days as a 
result of treatment (P = 0.98). Analysis of subsequent 21-day intervals showed no differences 
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between treatment in the number of calves born in each interval (P ≥ 0.33). As expected, with no 
differences in calving distribution, there was also no difference in calving interval between the 
2016 and 2017 calving season (DOR = 371 d; EPR = 370 d; P = 0.72).  
 
4.4.4 Fecal Egg Counts 
Fecal samples were collected from a subset of five cooperator herds at the start and end of 
the grazing season for evaluation of FEC as well as coproculture if warranted. Of the five herds 
sampled, two DOR and four EPR groups warranted coprocultures from samples collected at the 
start of the grazing season. Species identified in DOR groups were predominantly comprised of 
Cooperia (100%, 81% and 76%) and Haemonchus (19% and 24%). Similarly, EPR groups 
consisted primarily of Cooperia (100%, 100%, 82% and 55%) followed by Haemonchus (18% 
and 12%). Other species detected in the EPR group were Oesophagostomum (12%) and 18% of 
larvae cultured were too damaged to identify. No coprocultures were warranted for fecal samples 
taken at the end of the grazing season.  
Fecal egg count data is reported in Table 4. Efficacy is most commonly measured using fecal 
egg reduction tests (FECRT), which compares fecal egg counts before and after treatment with 
an anthelmintic to measure the reduction in or elimination of fecal egg shedding (Taylor et al., 
2002; Coles et al., 2006). While initial FEC were not different between treatment groups in this 
study (P = 0.89), final FEC were lower (P = 0.02) in EPR cows compared to DOR cows. 
Subsequently, EPR cows had a greater overall reduction in FEC compared to DOR cows (P = 
0.01). However, FEC of both treatments at both treatment and at final performance measurement 
were far below a threshold that would be indicative of clinical parasitism (Bagley et al., 1998). 
We believe that a lack of parasitic infection during the grazing season may have resulted in a 
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lack of performance differences in this study. Low FEC may be a reflection of the types of herds 
that were selected to participate in this study. Because of the stringent requirements to qualify for 
participation, herds selected were uncommonly well-managed which likely contributed to low 
overall FEC. In similar studies, consisting of treatments that included positive control groups and 
comingled treatments, both Pfeifer et al. (1999) and Ward et al. (1991) saw similar FEC during 
the course of the respective trials and reported no performance differences following 
anthelmintic treatment. This indicates, in agreeance with previous work, the level of parasitic 
infection in the current study may not have been high enough to elicit a production response. 
However, it should be noted that Clark et al. (2013) was able to detect significant differences in 
performance between commingled ivermectin and extended release eprinomectin treated stocker 
calved that had FEC of 5.14 and 0.90, respectively.  
 
4.4.5 Calf Performance  
Results for calf growth and performance are reported in Table 5. There were no differences in 
birth BW for calves regardless of tier or calving season (P = 0.57). Because fall-calving herds 
were treated in the spring while cows were pregnant, birth weights of fall calves were analyzed 
as possible fetal programing response to treatment. However, analysis of birth weights of fall 
calves indicated no difference between treatments (P = 0.43; data not shown). Calf BW at time 
of treatment for calves in tier two was not different (P = 0.50). Likewise, weaning weights were 
not different between the two treatment groups regardless of tier or calving season (P = 0.75), 
although as expected there was a season effect (P ≤ 0.01) where fall calves were lighter at 
weaning than spring calves. Subsequently, ADG between time of treatment and weaning was not 
different (P = 0.28), and overall pre-weaning ADG did not differ due to treatment (P = 0.57). 
72 
 
While little comparable literature exists for evaluation of a short duration and extended release 
anthelmintic, Backes (2016) found increased WW for calves from dams treated with oral 
oxfendazole compared to calves from dams treated with extended-release eprinomectin. While 
milk production has been previously implicated in improved performance of pre-weaned calves 
(Frechette and Lamothe, 1981; Ciordia et al., 1982; Stromberg et al., 1997), a lack of 
performance differences in cows makes it an unlikely mechanism in the present study. Likewise, 
low FEC found in cows suggest low worm burdens, possibly a result of well managed pastures, 
which may have correlated to low levels of parasitic infection in calves.  However, pre-weaning 
anthelmintic treatment may have implications for improved performance later in both stocker 
and feedlot phases. Stacey et al. (1999) found that pre-weaning treatment with a sustained-
release ivermectin bolus improved stocker weight gains compared to calves treated with a 
conventional ivermectin pour-on. Clark et al. (2015) found that calves entering the feedlot with a 
higher worm burden had reduced growth, compromised immunocompetency, and altered carcass 
composition compared to steers with low fecal egg counts even though both groups were treated 
upon feedlot arrival. Furthermore, Clark et al. (2015) suggest that not only do calves with a 
lesser parasite burden have improved pre-weaning performance, but that early parasite protection 
may improve lifetime production. 
 
4.4.6 Feedlot Performance and Carcass Characteristics 
 Feedlot performance and carcass measurements are presented in Table 6. There was no 
difference in BW between DOR and EPR calves at initiation of the feeding period (P = 0.20). 
Subsequent BW taken at re-implantation approximately 50 days after initiation of feeding 
showed a tendency for EPR treated calves to weigh more (P = 0.07). While not statistically 
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different (P = 0.13), EPR treated calves did finish with a slight weight advantage compared to 
DOR calves. Although EPR calves finished with slightly heavier weights throughout the feeding 
period, this did not correlate into differences in ADG (P ≥ 0.31) between treatments. However, 
when evaluating health of calves in the feedlot, EPR calves were treated for various health issues 
fewer times compared to DOR calves (P = 0.05) indicating improved health status. While all 
essential components of the immune system are present at birth, full functionality of immunity is 
not possibly until 2-4 weeks of age and may continue to develop through puberty (Wilson et al., 
1996; Chase et al., 2008). Because DOR calves were protected from parasitic infection for a 
shorter period of the grazing season, as were their dams, exposure to parasites may have 
occurred. Because parasites can impair or even inhibit immune response (Gomez-Munoz et al., 
2004), an infection during this critical stage of development may have resulted in impaired 
development of the immune system thus impacting lifetime immunocompetency. Although FEC 
in this study were low, calves are more susceptible to parasites, and although immediate 
performance was not impacted, disruption of immune development may have been occurred 
resulting in higher feedlot morbidity.  
Subsequent carcass measurements showed no differences due to treatment including 
HCW, KPH, or backfat (BF; P ≥ 0.22). Likewise, REA and YG were similar (P ≥ 0.60) between 
treatments. Calves treated with EPR had a higher marbling score as well as higher average 
quality grade (P ≤ 0.01). This resulted in difference in quality grade distribution where EPR 
calves have a greater percentage of carcasses grade average choice or higher compared to DOR 
(38.4% DOR; 49.7% EPR; P = 0.03). However, there were no differences in the number of 
carcasses that graded low choice or select and lower (P ≥ 0.37). Gardner et al. (1999) reported 
that feedlot morbidity results in a reduction in quality grade, with a higher percentage of steers 
74 
 
identified as sick grading Standard. Therefore, reduced morbidity and improved quality grade 
create potential for a greater return on initial anthelmintic treatment. The results of this study are 
in agreeance with those of Gardner et al. (1999) where DOR calves had a higher incidence of 
morbidity, resulting in an increased health cost, and had a lower average quality grade as well as 
fewer calves grading average choice or higher compared to healthier EPR calves.  
These results are in line with previous studies. Clark et al., 2013 found that while calves 
treated with extended-release eprinomectin performed better than calves treated with injectable 
ivermectin during the stocker phase, this did not translate into improved feedlot performance or 
carcass characteristics. Likewise, Backes (2016) noted improved growth during the stocker 
phase, but saw no difference in HCW, marbling score, backfat, KPH, YG, or quality grade 
distribution between calves treated with extended-release eprinomectin or oral oxfendazole at 
weaning. Again, low FEC at initiation of the present study may have resulted in a lack of 
performance throughout all phases of production. 
 
4.5 Economic Impact 
4.5.1 Cow/Calf  
Performance responses were evaluated for differences in economic value between 
treatment groups. Variables considered as economically relevant in the cow-calf analysis include 
cow BW, overall breeding season pregnancy rates, calving interval, calving distribution, and calf 
weaning BW. As seen by production measurements presented in Tables 1 and 2, little variation 
exists between treatment groups. Overall breeding season pregnancy rates were not different 
indicating a lack of evidence for increased return on investment through increased calf crop. 
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Likewise, calving interval and calving distribution were not different, and there were no 
differences in calf performance.  
A lack of differences in the current study provides little opportunity for EPR cows to 
recoup the increased cost of treatment during the pre-weaning phase. Therefore, the cow-calf 
analysis sought to determine increased production, in kilograms of calf weaned, necessary for the 
respective treatments to be indifferent. Because treating with DOR is considered a conventional 
practice, the improved performance needed by EPR calves in order to negate the cost difference 
between treatments was also evaluated.  
The partial budget for this analysis is organized into two categories—expenses and income 
associated with the change. In the present study, this considers a change from DOR to EPR 
treatment.  
 
4.5.1.1 Expenses. Because expenses such as forage, feed, labor, and reproduction were the same 
irrespective of treatment, only costs associated with differences in anthelmintic treatment were 
considered. Based on drug prices at the time of treatment, DOR costs $0.32/cc and EPR costs 
$1.38/cc. The average amount of medicine administered for cows and calves was 12cc and 3cc, 
respectively, for both treatments. This resulted in a cost of $5.01 per cow-calf pair treated with 
DOR and a cost of $21.39 per cow-calf pair treated with EPR. Cost difference between EPR and 
DOR treatments was $16.38/pair. 
 
4.5.1.2 Income. Income was determined by evaluating pounds of calf weaned at the market price 
on the average date of weaning for cooperating herds. A market price of $3.40/kg (Iowa auction 
average for Sept. 2016) was used (USDA-AMS, 2016).  
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Results from the economic analysis are reported in Table 7. This analysis indicates that 
EPR cows would need to wean calves with a 4.8 kg weight advantage over DOR calves in order 
to eliminate the difference in cost between treatments. For producers to recoup the cost of the 
specific anthelmintic in cow-calf production, DOR and EPR calves would need to add 1.5 kg and 
6.3 kg by weaning, respectively. The sensitivity of kilograms of weaned calf required to pay for 
the cost of anthelmintic treatment at alternative calf prices are reported in Table 7. Results of the 
sensitivity analysis indicate, as expected, that the added weight necessary for a producer to 
recoup the cost of anthelmintic treatment was highly variable depending on the market price.  
While it may not be efficient to retain open females in a herd, attention to management 
and marketing of cull cows can impact profitability. Cull cows can represent up to 10-20% of 
total revenue within the cow-calf enterprise (Peel and Doye, 2008). While marketing is 
important, management strategies alone can increase cull cow value by 25 to 45% (Peel and 
Doye, 2008). Increase pounds of animal sold can result in increased revenue at comparable 
prices. Therefore, the use of a specific anthelmintic could improve cow-calf returns through 
increased cull cow values. While there were no differences in cow BW at weaning, evaluation of 
BW differences between open cows in each treatment group were analyzed for opportunities for 
increased cull cow value. Analysis shows a slight weight advantage for open DOR cows 
compared to open EPR cows (577 kg DOR; 571 kg EPR; data not shown) (Table 5). This slight 
weight advantages creates an opportunity for producers to realize a greater return, on average, 
from cull animals treated with DOR. With an average cull cow price of $1.56/kg from October 
2016 (Sioux Fall, SD) (USDA-AMS, 2016), DOR cows had the potential to have an increased 
return of $9.23/head (Table 7). It is also important to note the reduction in incidence of pinkeye 
in EPR cows. This also provides an opportunity, through reduced health and labor costs, to 
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increase returns on the initial cost of anthelmintic treatment. Thus, improved performance in the 
form of added weight for either weaned calves or cull cows and improved herd health have the 
potential to improve return on investment for pre-weaning anthelmintic treatment for the cow-
calf enterprise.  
While not evident in the current study, performance increases necessary to offset cost of 
treatment during the pre-weaning phase may be possible in alternative environments such as 
those with higher levels of parasitic infections. Data evaluating the use of extended-release 
eprinomectin compared to a conventional ivermectin injectable in fall-calving beef herds has 
shown improvements in conception to AI as well as overall breeding season pregnancy rates 
(Andresen et al., 2017). Therefore, improvements in reproductive efficiency manifested as 
greater overall season pregnancy rates following anthelmintic treatment may provide 
opportunities for a greater return on investment.  
The same study also found reduced calving interval and a shift in calving distribution in 
the calving season following initial anthelmintic treatment for cows treated with EPR, as well as 
increased weaning weights for their calves. Thus, a reduced calving interval and a shift in 
calving distribution following anthelmintic administration may improve the probability of 
weaning heavier calves. Data from Funston et al. (2012) shows that steers and heifers born in the 
first 21-day calving period perform better than cohorts born in later calving periods. Shifting 
calving distribution may also improve cow pregnancy rates by increasing the post-partum 
recovery time. This may result in a larger calf crop as well as increased pounds of calf weaned 
per cow. These data indicate alternative conditions to the ones in the current study have the 
potential to generate a greater return on investment following treatment with EPR. However, it is 
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important to note that improvements in returns based on improved performance will be highly 
dependent on the economic conditions at the time calves are marketed.  
It is also important to note that estimates from this analysis are likely conservative. The 
comparison in the current study was made between extended-release eprinomectin and a single 
treatment of a short duration anthelmintic. Because the goal of this study was not to compare the 
effectiveness of deworming, no comparison was made using a short duration anthelmintic 
multiple times throughout the grazing season to create an equal number of protected days as 
EPR, which would have increased initial treatment costs for DOR. The goal of the current study 
was to evaluate extended-release eprinomectin compared to conventional dewormers in common 
production settings where deworming typically occurs once during the grazing season which was 
also the basis of the economic analysis conducted.  
 
4.5.2 Feedlot  
The enterprise budget for this analysis used actual income and expense records for each 
treatment group and prices reported by TCSCF. 
 
4.5.2.1 Expense. Costs including feed, interest, death loss, and yardage were assumed equal 
between treatment groups as these costs were accrued regardless of anthelmintic treatment. 
Because there were no differences in WW, placement cost at time of delivery was the same for 
each group ($2.60/kg) based off reported market price at time of delivery by TCSCF. Records 
obtained through TCSCF allowed for individual animal health records including how many times 
a calf was treated and the cost of health treatments throughout the feeding period. Calves treated 
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with DOR pre-weaning had a greater number of health issues (Table 6) throughout the feedlot 
phase resulting in higher health costs of $6.00 per animal.  
 
4.5.2.2 Income. Fed cattle prices used were the average price received by producers in this study 
as reported by TCSCF. Average final BW was used to determine the live value of animals within 
each treatment group. This price accounted for premiums and discounts that were paid for 
various quality, yield, and weight characteristics. Although quality grade distribution presented 
in Table 6 indicates a larger number of carcasses grading average choice or greater for EPR 
treated calves, premiums for YG, CAB, and prime were consistent between the two treatment 
groups. This may have been a result of variability in marketing time as market dates for finished 
cattle ranged from March 21, 2017 to July 18, 2017. While fed cattle price was not different 
between treatment groups ($2.87/kg), EPR calves did finish the feedlot phase with a slight 
weight advantage over DOR calves (550 kg DOR; 557 kg EPR) resulting in a slight increase in 
income on a live weight basis. 
Results of the feedlot budget analysis are reported in Table 6. The culminating effect of 
both healthier and heavier EPR calves resulted in a lower breakeven price ($1.10 DOR vs. $1.08 
EPR) and an opportunity for slightly higher profits ($200.11 DOR; $227.22 EPR) per animal. 
 
4.5.3 Retained Ownership 
As seen by slightly higher returns for EPR calves in the feedlot, administering EPR pre-
weaning may be able to make up the cost difference between the two anthelmintic treatments. 
For producers operating on a retained ownership platform, like cooperating herds in this 
study, opportunities to capitalize on a higher calf-hood deworming investment are much greater. 
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While a lack of differences in the cow-calf portion of this study indicated little potential for 
improved returns for cow-calf production alone, improved immunocompetency and higher final 
BW of EPR calves may allow producers to realize a return on investment of the original 
treatment given pre-weaning.  
While, on average, participating cooperator herds anecdotally noted returns on the added 
cost of extended-release eprinomectin, variability in market conditions over time will greatly 
impact economic outcomes for environments outside of the current study. Returns realized by 
implementing a value-added practice will be highly impacted by differences in cattle prices at 
key marketing times including weaning, backgrounding, or finishing. While retained ownership 
may increase price risk due to delayed marketing and potentially added price volatility, cow-calf 
producers have opportunities to mitigate some production risk through value added practices 
such as preventative health protocols that reduce performance variability (White et al., 2007).      
 
4.6 Conclusion 
To our knowledge, this is one of two studies published to date that evaluates the effect of 
extended-release eprinomectin on cow-calf production and feedlot performance of progeny 
compared to a conventional, short duration anthelmintic. The results of this study show no 
difference in cow performance or reproductive success over the course of the grazing season. 
Likewise, there were no improvements in calf pre-weaning performance or feedlot performance.  
While carcass characteristics were largely unchanged due to treatment, there was an 
improvement in quality grade for EPR treated calves. Improved immunocompetency via 
extended parasite protection during the preweaning phase may have had long-term impacts on 
feedlot morbidity resulting in improved quality grade measurements. This was evident by a 
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lower percent of illness during the feeding phase, increased marbling score, a higher average 
quality grade, and a higher percent of EPR calves grading average choice or higher, presenting a 
chance to increased returns to producers by have more animals qualify for value-added 
programs.  
It is important to note that FEC counts were very low in this study and may have 
provided very little opportunity for performance improvement following anthelmintic treatment 
in both treatment groups. Thus, more research is needed in populations carrying greater parasitic 
burdens to evaluate the effect of extended-release eprinomectin on cow-calf production. 
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Table 1: Requirements for cooperator herds to participate. 
Cow Response Variables of Interest Calf Response Variables of Interest 
Body weight 
 Treatment 
 Off-study 
Body weight 
 Treatment 
 Weaning 
 
 
 
Health outcomes 
 Pinkeye 
 Fly burden 
 BRD treatments in feedlot 
 
 
 
Feedlot performance 
 Feedlot ADG 
 Health 
 Carcass characteristics 
 Carcass value/income 
 
BCS 
 Treatment 
 Off-study 
  
Health outcomes 
 Pinkeye 
 Fly burden 
 
Fecal egg counts 
 Initial 
 Final 
 
Reproduction end points 
 Conception to AI 
 Overall breeding season pregnancy rates 
 Calving distribution 2017 
 Calving Interval between 2016 and 2017                    
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Table 2: Age, calving date, birth weight, treatment date, days postpartum, BW, and BCS of cows from cooperating herds enrolled in the study.  
Herd1 n 
Mean age, 
yr (range) 
Julian calving date, 
mean and range 
Calf birth weight, 
mean and range 
Dam treatment date2, 
mean and range 
Days postpartum3, 
mean and range 
Mean BW, 
kg (range) 
Mean BCS4, 
(range) 
1 75 5.4 
(2 to 13) 
56 
(16 to 97) 
36 
(25 to 49) 
160 
(160 to 161) 
104  
(63 to 144) 
576 
(431 to 750) 
5.5 
(4.0 to 9.0) 
2 51 4.8 
(2 to 11) 
58 
(23 to 101) --- 
124 
(121 to 128) 
69 
(27 to 105) 
582 
(452 to 716) 
6.0 
(4.0 to 8.0) 
3 40 5.1 
(3 to 10) 
90 
(12 to 201) --- 
91 
(---) 
0.6 
(-110 to 79) 
591 
(448 to 740) 
6.2 
(4.0 to 8.0 
4 164 4.9 
(2 to 13) 
23 
(-2 to 57) 
33 
(21 to 49) 
89 
(81 to 104) 
67 
(26 to 93) 
541 
(350 to 769) 
5.81 
(4.0 to 8.0) 
5 194 4.8 
(2 to 12) 
18 
(-18 to 109) --- 
139 
(122 to 153) 
120 
(44 to 166) 
621 
(376 to 858) 
4.3 
(3.0 to 6.0) 
6 67 4.2 
(2.0 to 11) 
72 
(125 to 136) --- 
128 
(125 to 136) 
56 
(19 to 91) 
658 
(372 to 803) 
4.3 
(3.0 to 6.0) 
7 402 5.7 
(2 to 14) 
127 
(16 to 290) 
37 
(18 to 52) 
150 
(116 to 166) 
69 
(31 to 143) 
522 
(306 to 796) 
5.7 
(3.3 to 8.0) 
8 129 5.2 
(2 to 15) 
142 
(19 to 291) 
39 
(23 to 56) 
140 
(126 to 147) 
60 
(14 to 128) 
621 
(495 to 782) 
5.4 
(4.0 to 7.3) 
9 188 6.2 
(2 to 14) 
109 
(51 to 268) 
37 
(27 to 45) 
131 
(130 to 133) 
49 
(7 to 79) 
602 
(413 to 759) 
5.4 
(4.3 to 7.3) 
10 118 4.3 
(2 to 16) 
85 
(45 to 148) 
34 
(20 to 49) 
127 
(126 to 132) 
43 
(-22 to 87) 
566 
(395 to 744) 
5.5 
(4.0 to 7.5) 
11 90 3.9 
(2 to 10) 
81 
(57 to 112) 
33 
(21 to 43) 
126 
(---) 
45 
(14 to 69) 
537 
(372 to 779) 
5.7 
(4.0 to 8.0) 
12 248 5.8 
(2 to 15) 
110 
(79 to 167) 
35 
(16 to 51) --- --- --- --- 
Overall 1,766 5.3 
(2 to 16) 
89 
(-19 to 291) 
36 
(16 to 56) 
133 
(81 to 166) 
70 
(-110 to 166) 
568 
(306 to 858) 
5.4 
(2.0 to 9.0) 
1Herds were located in seven different states. 
2Julian date of treatment within a herd. 
3Days postpartum at anthelmintic administration. 
4Body condition score on 1 to 9 scale (1 = emaciated and 9 = obese; Wagner et al., 1988) 
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Table 3: Performance of cows treated with different anthelmintic treatments during the grazing 
season. 
 Treatment1   
Item DOR EPR SEM P-Value3 
BW, kg     
   Treatment 577 578 11.4 0.85 
   Weaning 587 590 10.8 0.40 
   Change in4, kg 9 12 4.7 0.13 
   Change in4, % 1.95 2.67 0.81 0.12 
Performance     
   ADG4, kg 0.05 0.08 0.04 0.23 
BCS     
   Treatment 5.57 5.57 0.07 0.99 
   Weaning 5.58 5.60 0.09 0.59 
   Change in 0.00 0.02 0.08 0.67 
1Treatment: DOR = doramectin (Dectomax; Zoetis Animal Health, Parsippany); EPR = 
eprinomectin (LongRange; Merial, Duluth, GA). 
2Larger SEM presented (n = 828 DOR; n = 832 EPR). 
3P-value: Significant P ≤ 0.05; Tendency 0.05 < P ≤ 0.10. 
4Calculations based on weight changes from treatment to weaning/end of grazing season. 
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Table 4: Health and reproductive success of cows treated with different anthelmintic treatments 
during the grazing season. 
 Treatment1   
Item DOR EPR SEM P-Value3 
FEC     
   Initial 2.07 2.97 0.49 0.18 
   Final 1.76 0.71 0.34 0.02 
   Change in  -0.30 -2.12 0.60 0.01 
Health     
   Cow Pinkeye, % 8.4 4.6 --- 0.06 
   Calf Pinkeye 19.5 21.1 --- 0.43 
   Live Fly Counts  62 60 11.3 0.62 
   Picture Fly Counts 50 58 11.8 0.69 
Reproduction, % (no./no.)     
   Conception to AI 47 (157/334) 50 (164/327) --- 0.51 
   Pregnancy Rate4 88 (729/828) 88 (733/832) --- 0.45 
Calving Interval5, d 371 370 2.1 0.72 
1Treatment: DOR = doramectin (Dectomax; Zoetis Animal Health, Parsippany); EPR = 
eprinomectin (LongRange; Merial, Duluth, GA). 
2Larger SEM presented (n = 828 DOR; n = 832 EPR). 
3P-value: Significant P ≤ 0.05; Tendency 0.05 < P ≤ 0.10. 
4Pregnancy rate for 2016. 
5Calving interval from 2016 to 2017 calving. 
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Table 5: Performance and health of calves who were treated with different anthelmintic 
treatments during the grazing season.  
 Treatment1   
Item DOR EPR SEM P-Value 
BW, kg     
   Birth 35 35 0.6 0.57 
   Treatment 142 141 7.4 0.50 
   Weaning4 231 232 5.5 0.75 
Performance, kg     
   Treatment ADG5 1.02 1.04 0.04 0.34 
   Weaning ADG6 1.05 1.05 0.02 0.66 
Health, %     
   Pinkeye 18.6 21.1 --- 0.43 
1Treatment: DOR = doramectin (Dectomax; Zoetis Animal Health, Parsippany); EPR = 
eprinomectin (LongRange; Merial, Duluth, GA). 
2Larger SEM presented (n = 828 DOR; n = 832 EPR). 
3P-value: Tendency 0.05 < P ≤ 0.10. 
4Actual weaning weight. 
5Calculation based on weight change from time of anthelmintic treatment to weaning. 
6Calculation based on weight change from birth to weaning. 
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Table 6: Feedlot and carcass characteristics of calves who were treated with different, pre-
weaning anthelmintic treatments. 
 Treatment1   
Item DOR EPR SEM2 P-Value3 
BW, kg     
   Initial 367 374 14.5 0.20 
   Re-Implant 442 453 11.1 0.07 
   Final 555 560 9.6 0.13 
Performance, kg     
   ADG 1.62 1.60 0.15 0.33 
Health     
   Treated, % 22.4 13.6 --- 0.05 
Carcass Quality     
   HCW5, kg 345 348 5.9 0.22 
   Dress6, % 61.7 61.9 0.00 0.24 
   Backfat, cm. 1.39 1.37 0.07 0.55 
   KPH7, % 2.28 2.23 0.08 0.12 
   Ribeye area8, cm.2 81.90 82.25 1.14 0.58 
   Yield grade9 2.55 2.58 0.11 0.61 
   Marbling score10 1081 1101 12.6 0.01 
   Quality grade11 12.27 12.56 0.14 <0.01 
% QG Distribution12     
   Avg choice or Higher 40.38 51.43 --- 0.03 
   Low choice 47.31 41.43 --- 0.63 
   Select and lower 12.31 7.14 --- 0.37 
1Treatment: DOR = doramectin (Dectomax; Zoetis Animal Health, Parsippany); EPR = 
eprinomectin (LongRange; Merial, Duluth, GA). 
2Larger SEM presented (n = 238 DOR; n = 259 EPR). 
3P-value: Significant P ≤ 0.05; Tendency 0.05 < P ≤ 0.10. 
4Hot carcass weight. 
5Dressing percent. 
6Kidney, pelvic, heart fat. 
7Marbling score: small: 1,0000, modest: 1,1000, moderate: 1,2000, etc. 
8USDA quality grade: 12: Choice-, 13: Choice0, 14: Choice+, etc. 
9Percentage of steers in each treatment by quality grade, within treatment total is 100%. 
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Table 7. Economic analysis and break-even weight for calves and cull cows treated with 
different anthelmintic treatments during pre-weaning. 
 Treatment1  
 DOR EPR Difference2 
Herd size3 100 100 --- 
Cost of Treatment $5.01 $21.39 $16.38 
Average WW, kg 238 238 --- 
Breakeven weight needed4, kg    
   $2.73/kg 1.8 7.9 6.0 
   $3.40/kg5 1.5 6.3 4.8 
   $4.06/kg 1.2 5.3 4.0 
Average cull cow weight, kg. 577 571 6 
Cull cow value6, $/hd $902.41 $893.78 $9.23 
1Treatment: DOR = doramectin; EPR = eprinomectin. 
2Cost difference that must be made up by EPR calves in order to breakeven with a conventional 
treatment. 
3Budget utilized from Texas Extension Cooperative (2002). 
4Added weaning weight necessary above average WW for treatments to breakeven at various 
market prices. 
5Weighted average market price of medium to large, frame 1, 227-249 kg fed calves for Iowa 
auctions on September 2016.  
6Value calculated based on October 2016 Boning cow 544-907 kg prices reported from Sioux 
Falls, SD.   
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Table 8. Economic analysis and break-even prices for feedlot animals treated with different 
anthelmintic treatments pre-weaning. 
 Treatment1  
$/steer2 DOR EPR Difference2 
Total costs $1,375.49 $1,369.18 $6.31 
Income $1,576 $1,596 $21 
Profit $200.11 $227.19 $27.08 
Breakeven selling price, ($/kg)    
   For variable costs $2.43 $2.38 $0.05 
   For all costs $2.49 $2.45 $0.04 
1Treatment: DOR = doramectin; EPR = eprinomectin 
2Budget utilized from Iowa State University Extension and Outreach (Ag Decision Maker, B1-
21). All market prices were average of actual market values obtained through Tri-County Steer 
Carcass Futurity (TCSCF) records.   
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CHAPTER 5. 
GENERAL DISCUSSION 
Gastrointestinal parasites create nutritional inefficiencies in the host they infect. This is 
accomplished through reduced feed intake and altered protein metabolism. These inefficiencies 
can alter nutrient partitioning and impact lower priority functions such as growth and 
reproduction. These alterations can be especially detrimental in growing, developing, or 
reproducing animals that may be highly impacted by nutritional deficiencies as well as hard to 
identify. Anthelmintic treatment has been shown to reduce worm burdens and improve efficiency 
in parasitized animals, thus improving measurable performance parameters. Deworming has long 
been utilized in agriculture production settings, but development of new products has been 
stagnant for the last decade. A recent introduction of a novel anthelmintic drug has given 
producers new option in parasite protection 
While introduction of this novel anthelmintic, extended-release eprinomectin, has 
provided a unique alternative, it comes with an increased out of pocket cost and a number of 
unknowns. Conventional anthelmintic treatment has long been proven to improve performance 
compared to non-treated controls across all sectors of the beef industry. However, extended-
exposure to anthelmintic compounds such as extended-release eprinomectin has not been 
studied. Impacts on performance, particularly reproduction in cows and bulls are of interest as 
these parameters have not been largely studied, with either an extended-release or short duration 
anthelmintic. While there has been a great interest in the use of extended-release eprinomectin 
due to its extended length of protection throughout the grazing season, anecdotal evidence of 
both fly control and reduced incidence of pinkeye, assumed to have a cause and effect 
relationship, have caught the attention producers throughout all phases of beef production. The 
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experiments conducted in this thesis were aimed at elucidating the effects of extended-release 
eprinomectin on economically relevant production parameters in cow/calf production, 
particularly, reproductive success as well as evaluating anecdotal evidence of added benefits. 
Additionally, lifetime performance of progeny was assessed.  
As reported in Chapter 3, growth and reproductive success were greatly improved in both 
mature cows and replacement heifers following administration of extended-release eprinomectin 
compared to a conventional, short duration dewormer. The improvement in overall breeding 
season pregnancy rates, shortened calving interval, and calving interval coupled with improved 
maintenance of body condition and weight indicate improved nutritional status of the animals 
following anthelmintic treatment. Furthermore, weaning BW of their offspring, who were 
younger than cohorts whose dams were treated with a conventional dewormer, may be indicative 
of increased milk production.  
Results from Chapter 4 indicate little difference in performance between extended-release 
eprinomectin and conventionally treated cattle. It is interesting to note that health parameters 
seemed to be the most improved, noted by both a decreased in pinkeye in EPR treated cows and 
reduced feedlot morbidity in EPR treated calves. While FEC were low throughout the study, 
subtle improvements in immunocompetence were noted. This is interesting, as nutrient allocation 
theories have suggested expression of immunity may be prioritized beneath growth and 
reproduction during a parasitic infection. The fly control properties that have been associated 
with extended-release eprinomectin have thought to be the cause for reduced incidence of 
pinkeye. Although this relationship is conceivable, there was no correlation between the two in 
this study. It is possible that improved immunity following deworming may be correlated to the 
reduced health issues, as feedlot morbidity was reduced for calves treated with extended-release 
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eprinomectin. Perhaps infections were low enough that performance was not impaired, but high 
enough to impede immune response. However, improved immunocompetence of EPR animals 
provides opportunities to increase return on the cost of initial treatment and was most evident for 
producers who retained ownership through the feedlot phase.  
While the results of the studies presented in Chapter 2 and 3 are inconsistent, they 
demonstrate the variability in performance responses to anthelmintic treatment in different 
environments. Because of the subclinical nature of most parasitic infections, production 
responses following anthelmintic treatment can be unpredictable and may depend on several 
factors including level of infection, management practices, nutrition and overall health of the 
herd.  
While variable, the results presented in this thesis indicate possible production responses 
following administration of extended-release eprinomectin. Furthermore, opportunities may exist 
to capitalize on initial treatment through improved performance and retained ownership. 
However, implementation of extended-release eprinomectin into herd health protocols warrants 
more research, particularly into environments with varying parasitic infections to the ones noted 
in these studies.  
 
 
 
 
 
 
 
93 
LITERATURE CITED 
Abbott, E.M., J.J. Parkins, and P.H. Holmes. 1988. Influence of dietary protein on the 
pathophysiology of haemonchosis in lambs given continuous infections. Res. Vet. Sci. 
45:41-49. 
Ag Decision Maker. 2017. Feedlot Enterprise Budget B1-21. Iowa State University Extension 
and Outreach.  
Amaradasa, B.S, R.A. Lane, and A. Manage. 2010. Vertical migration of Haemonchus contortus 
infective larvae on Cynodon dactylon and paspalum notatum pastures in response to 
climate change. Vet. Parasitol. 170:78-87. doi:10.1016/j.vetpar.2010.01.026 
Anderson, R. 2000. Nematode Parasites of Vertebrates Their Development and Transmission 
(2nd ed.). Wallingford: CAB International. 
Andresen, C.E., D.L. Loy, T.A. Brick, and P.J. Gunn. 2017. Effects of extended-release 
eprinomectin on cow/calf performance and reproductive success in a fall-calving beef 
herd. Prof. Anim. Sci. (Accepted).  
Anziani, O.S., V. Suarez, A.A., Guglielmone, O. Warnke, H. Grande, and G.C. Coles. 2004. 
Resistance to bendimidazole and macrocyclic lactone anthelmintics in cattle nematodes 
in Argentina. Vet. Parasitol. 122L303-306. doi:10.1016/j.vetpar.2004.05.018 
Armour, J. 1980. The epidemiology of helminth disease in farm animals. Vet. Parasitol. 6:7-46. 
doi:10.1016/0304-4017(80)90037-0 
Armour, J. and M. Duncan. 1987. Arrested larval development in cattle nematodes. Parasitol. 
Today. 3(6):171-176. doi:10.1016/0169-4758(87)90173-6 
Armour, J., W.F.H. Jarrett, and F.W. Jennings. 1966. Experimental Ostertagia circumcincta 
infections in sheep: development and pathogenesis of a single infection. Am. J. of Vet. 
Res. 27:1267-1278. 
Backes, E.A. 2016. Evaluation of long-acting eprinomectin compared to conventional 
anthelmintics in cow-calf production. Doctoral dissertation. University of Arkansas. 
1677. 
 
Bagley, C., M.C. Healey, and D. Hansen. 1998. Internal parasites in cattle. Beef Cattle 
Handbook. BCH-3305. 
Bairden, K. and J. Armour. 1981. A survey of abomasal parasitism in dairy and beef cows in 
south-west Scotland. The Veterinary record 109(8): 153-155. doi:10.1136/vr.109.8.153 
Ballweber, L.R. 2014. Gastrointestinal nematode infections in cattle. pp 1503-1506 in: Large 
animal internal medicine, 5th edition. B. Smith. ed. Elsevier Mosby, St. Louis, Missouri.  
94 
Ballweber, L.R., L.L. Smith, J.A. Stuedemann, T.A. Yazwinski and T.L. Skogerboe. 1997. The 
effectiveness of a single treatment with doramectin or ivermectin in the control of 
gastrointestinal nematodes in grazing yearling stocker cattle. Vet. Parasitol. 72:53-68. 
doi:10.1016/S0304-4017(97)00078-2 
Bang K.S., A.S. Familton, and A.R. Sykes. 1990a.  Effect of ostertagiasis on copper status in 
sheep:  a study involving use of copper oxide wire particles. Res. Vet. Sci. 49:306-314.  
Bang K.S., A.S. Familton, and A.R. Sykes. 1990b.  Effect of copper oxide wire particle 
treatment on establishment of major gastrointestinal nematodes in lambs. Res. Vet. Sci. 
49:132-137. 
Barth, D., D. Bernhard, and J. Lamina. 1981. The prevalence of gastro-intestinal nematodes in 
dairy cows. in Epidemiology and Control of Nematodiasis in Cattle. Springer 
Netherlands. Pp 117-130. 
Bauk, S.W., C.A. Piche and K.M. Newcomb. 1992. Effect of antiparasitic treatment in beef 
replacement heifers. Can. Vet J. 33:394-396.  
Beef Cattle Decision Aids. 2002. Economic Analysis of Select Health and Production 
Management Practices. Texas Cooperative Extension.  
Behnke, J.M., J. Hannah, and D.I. Pritchard. 1983. Evidence that adult Nematospiroides 
dubiusimpair the immune response to a challenge infection. Parasite Immunology, 5:397–
408. 
Besier, R.B., R.J. Love, J. Lyon, A.J. van Burgel. 2010. A targeted selective treatment approach 
for effective and sustainable sheep worm management: investigations in Western 
Australia. Anim. Prod. Sci. 50:1034–1042. doi:10.1071/AN10123 
Besier, R.B. 2012. Refugia-based strategies for sustainable worm control: factors affecting the 
acceptability to sheep and goat owners. Vet. Parasitol. 186:2-9 
doi:10.1016/j.vetpar.2011.11.057 
Blanchard, J.L. 1985.  Interaction of Ostertagia circumcincta and Haemonchus contortus in 
sheep. Diss. Abstr. Internat. 45:2067. 
Bliss, D.H., R.D. Moore, W.G. Kvaskicka. 2008. Parasite resistance in US cattle. AABP 
Proceedings. 41: 109-114. 
Borgsteede, F.H.M., J. Tibben, J.B.W.J. Cornelissen, J. Agneessens, and C.P.H. Gaasenbeek. 
2000. Nematodes of adult dairy cattle in the Netherlands. Vet. Parasitol. 89:287-296. 
doi:10.1016/S0304-4017(00)00219-3 
Bowman, D. D. 1999. Helminths. Pp 109-234 in: Georgis parasitologi for veterinarians, 7th 
edition. W.B Saunders Company, Philadelphia, Pennsylvania.  
95 
Bown, M.D., D.P. Poppi, and A.R. Sykes. 1986. The effect of postruminal infusion of protein or 
energy on the pathology of Trichostrongylus colubriformis infection and body 
composition in lambs. Proceedings of the New Zealand Society of Animal Production. 
46:27-30. 
Boyles, S.L., L.J. Johnson, W.D. Slanger, B.J. Kreft, and J.D. Kirsch. 1993. The effect of 
deworming naturally infected heifers on liveweight gain reproductive performance and 
fecal egg counts. Can. J. Anim. Sci. 73:287-293. doi:10.4141/cjas93-031 
Bremner, K. C. 1969. Pathogenetic factors in experimental bovine oesophagostomosis. III. 
Demonstration of protein-losing enteropathy with 51Cr-albumin. Exp. Parasitol. 24:364-
374. 
Bridges, A. and L. Lemenager. 2007. Impact of body condition at calving on reproductive 
productivity in beef cattle. Dept. Anim. Sci., Purdue University.  
Brundson, R.V. 1980. Principles of helminth control. Vet Parasitol. 6:185-215. 
doi:10.1016/0014-4894(69)90174-X 
Bumgarner, S.C., M.A. Brauer, R.M. Corwin, E.A. Thomas, and G.H. Meyers. 1986. Strategic 
deworming for spring-calving beef cow/calf herds. J. Am. Vet. Med. Assoc. 189:427-
431. 
Canton, J.S. and B.W. Hess. 2010. Maternal plane of nutrition: Impacts on fetal outcomes and 
postnatal offspring responses. Pages 104 – 122 in 4th Grazing Livestock Nutrition 
Conference. B. W. Hess, T. DelCurto, J.G.P. Bowman, and R.C. Waterman eds. West. 
Sect. Am. Soc. Anim. Sci., Champaign, IL. 
Charlier, J., E. Claerebout, E. De Muelenaere, and J. Vercruysse. 2005. Associations between 
dairy herd management factors and bulk tank milk antibody levels against Ostertagia 
ostertagi. Vet. Parastiol. 133:91-100. doi:10.1016/j.vetpar.2005.05.030 
Charlier, J., F. Vande Velde, M. van der Voort, J. Van Meensel, L. Lauwers, V. Cauberghe, J. 
Vercruysse, E. Claerebout. 2015. ECONOHEALTH: Placeing helmingh infections of 
livestock in an economic and social context. Vet. Parasitol. 212:62-67. 
doi:10.1016/j.vetpar.2005.05.030 
Charlier, J., M. van der Voort, F. Kenyon, P. Skuce, and J. Vercruysse. 2014. Chasing helminths 
and their economic impact on farmed ruminants. Trends in Parasitol. 30(7):361-367. 
doi:10.1016/j.pt.2014.04.009 
Charlier, J., M. van der Voort, H. Hogeveen, and J. Vercruysse. 2012. ParaCalc®—A novel tool 
to evaluate the economic importance of worm infections on the dairy farm. Vet. Parasitol. 
184:204-211. doi:10.1016/j.vetpar.2011.09.008 
96 
Charlier, J., V. De Waele, E. Ducheyne, M. van der Voort, F. Vande Velde, and E. Claerebout. 
2016. Decision making on helminths in cattle: diagnostics, economics and human 
behavior. Irish. Vet. J. 69:14-19. doi:10.1186/s13620-016-0073-6 
Chase, C.C.L., D.J. Hurley, and D.J. Reber. 2008. Neonatal immune development in the calf and 
its impact on vaccine response. Vet. Clin. Food. Anim. 24:87-104. 
doi:10.1016/j.cvfa.2007.11.001 
Chaudary, F.R., M. Qayyum, and J.E. Miller. 2008. Development and survival of Haemonchus 
contortus infective larvae derived from sheep feces under sub-tropical condition in the 
Potohar region of Pakistan. Trop. Anim. Health. Prod. 40:85-92. doi:10.1007/s11250-
007-9037-x 
Ciordia, H. and W.E. Bizzell. 1963. The effects of various constant temperatures on the 
development of the free living-stages of some nematodes parasites in cattle. J. Parasitol. 
49(1):60-63. doi:10.2307/3275675 
Ciordia, H., G.V. Calvert, and H.C. McCampbell. 1982. Effect of an anthelmintic program with 
morantel tartrate on the performance of beef cattle. J. Anim. Sci. 54:1111-1114. 
doi:10.2527/jas1982.5461111x 
Ciordia, H., H.C. McCampbell, G.V. Calvert, and R.E. Plue. 1984. Effect of ivermectin on 
performance of beef cattle on Georgia pastures. Am. J. Vet. Res. 45(11)2455-2457. 
Ciordia, H., R.E. Plue, G.V. Calvert, and H.C. McCampbell. 1987. Evaluation of the 
parasitological and production response of a cow/calf operation to an anthelmintic 
program with ivermectin. Vet Parasitol. 23:265-271. 
Claerebout, E. and J. Vercruysse. 2000. The immune response and the evaluation of acquired 
immunity against gastrointestinal nematodes in cattle: a review. Parasitol. 120 Suppl:S25-
42. doi:10.1016/0304-4017(87)90012-4 
Clark, C. A., P.J. Gunn, J. Dedrickson, and J. Sorenson. 2013. Comparison of ivermectin and 
extended-release eprinomectin deworming treatment on stocker and subsequent feedlot 
performance and carcass characteristics of fall-born angus heifers. Iowa State Research 
Farm Progress Reports. Paper 2103. 
Clark, C.A., W.D. Busby, and P.J. Gunn. 2015. Effects of internal infection at feedlot arrival on 
performance and carcass characteristics of beef steers. Prof. Anim. Sci. b31:412-416. 
doi:10.15232/pas.2014-01381 
Coles, G.C., C. Bauer, F.H.M. Borgsteede, S. Geerts, T.R. Klei, M.A. Taylor, and P.J. Waller. 
1992. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) 
methods for the detection of anthelmintic resistance in nematodes of veterinary 
importance. Vet. Parasitol. 44:35-44. doi:10.1016/0304-4017(92)90141-U  
97 
Coles, G.C., F. Jackson, W.E. Pomroy, R.K. Prichard, G. von Samson-Himmelstjerna, A. 
Silvestre, M.A. Taylor, and J. Vercruysse. 2006. The detection of anthelmintic resistance 
in nematodes of veterinary importance. Vet. Parasitol. 136:167-185. 
doi:10.1016/j.vetpar.2005.11.019 
Coles. G.C. 2002. Cattle nematodes resistant to anthelmintics: why so few cases? Vet Res. 
33:481-489. doi:10.1051/vetres:2002034 
Coop, R. L. and K.W. Angus. 1975. The effect of continuous doses of Trichostrongylus 
colubriformis larvae on the intestinal mucosa of sheep and on liver vitamin A 
concentration. Parasitol 70:1-9. doi:10.1017/S0031182000048800 
Coop, R.L, A.C. Field, R.B. Graham, K.W. Angus, and F. Jackson. 1986. Effect of concurrent 
infection with Ostertagia circumcincta and Trichostrongylus vitrinus on the performance 
of lambs. Res. Vet. Sci. 40:241-245. doi:10.1017/S0021859600082113 
Coop, R.L., F. Jackson, R.B. Graham, and K.W. Angus. 1988. The influence of two levels of 
concurrent infection with Ostertagia circumcincta and Trichostrongylus vitrinus on the 
growth performance of lambs. Res. Vet. Sci.45:275-280. 
Coop, R.L., I. Kyriazakis. 1999. Nutrition-parasite interactions. Vet. Parasitol. 84:187-204. 
doi:10.1016/S0304-4017(99)00070-9   
Copeman, D.B., G.W. Hutchinson. 1979. The economic significance of bovine gastrointestinal 
nematode parasitism in north Queensland. Proceedings of the Second International 
Symposium on Veterinary Epidemiology and Economics, Australian Government 
Publishing Service, Canberra, pp. 383–387 
Cox, W.R. and D. Lemiski. 1989. Prevelance of gastrointestinal nematodes in dairy heifers in 
western Canada. Can. Vet. J. 30:666-668. 
Craig, T.M. 1979. Seasonal transmission of bovine gastrointestinal nematodes in the Texas Gulf 
Coast. J. Am. Vet. Med. Assoc. 174(8), 844-847. 
Cringoli, G., L. Rinaldia, V. Veneziano, L. Mezzino, J. Vercruysse, F. Jackson. 2009. Evaluation 
of targeted selective treatments in sheep in Italy: effects on faecal worm egg count and 
milk production in four case studies. Vet. Parasitol. 164:36–43. 
doi:10.1016/j.vetpar.2009.04.010 
DeDonder, K.D., D.J. Rezac, K. Lechtenberg, S. Parimi and V. Singu. 2015. Comparison of the 
effects of Longrange™ and Dectomax™ on grazing performance and parasite burden in 
stocker cattle. Intern. J. Appl. Res. Vet. Med. 13(2):150-157. 
DeRoun, S.M., J.E. Miller, L.D. Foil and G.T. Gentry. 2009. Control of horn flies (Haematobia 
irritansI) and gastrointestinal parasites and its relation with cow-calf performance. Vet. 
Parasitol. 162:320-326. doi:10.1016/j.vetpar.2009.03.021 
98 
Drake, D.J., E.R. Atwill, R. Phillips and E. Johnson. 2001. Internal parasites prevalent in 
California’s beef cattle. Calif. Agricult. 55(2):28-32. doi:10.3733/ca.v055n02p28 
Dynes, R.A., A.E.L. Ankersmit, D.P. Poppi, G.K. Barrell, A.R. Sykes. 1990. Studies on the 
physiological basis of appetite depression in nematode infection in sheep. Proc. NZ Soc. 
Anim: Prod.  50:249-253. 
Entrocasso C.M., J.J Parkins, J. Armour, K. Bairden and P.N. McWilliam. 1986. Production, 
parasitological and carcass evaluation studies in steers exposed to tri-chostrongyle 
infection and treated with a morantel bolus or fenbendazole in two consecutive grazing 
seasons. Res. Vet. Sci. 40:76-85. 
Ferguson, E.G.W., G.B.B. Mitchell, and A. MacPherson. 1989. Cobalt deficiency and Oslertagia 
circumcincta infection in lambs. Vet. Rec. 124:20. 
Fiel. C.A., C.A. Saumell, P.E. Steffan, and E.M. Rodriguez. 2001. Resistance to Cooperia to 
ivermectin treatments in grazing cattle of the Humid Pampa, Argentina. Vet. Parasitol. 
97(3): 213-219. doi:10.1016/S0304-4017(01)00407-1 
Fitzpatrick, J.L. 2013. Global food security: the impact of veterinary parasites and 
parasitologists. Vet. Parasitol. 195:233-248. doi:10.1016/j.vetpar.2013.04.005 
Forbes, A.B., K.L. Cutler and B.J. Rice. 2002. Sub-clinical parasitism in spring-born, beef 
suckler calves: epidemiology and impact on growth and performance during the first 
grazing season. Vet. Parasitol. 104:339-344. doi:10.1016/S0304-4017(01)00640-9 
Fox N.J., G. Marion, R.S. Davidson, P.C.L. White, and M.R. Hutchings. 2013. Modelling 
parasite transmission in a grazing system: the importance of host behavior and immunity. 
PLoS ONE 8(11):e77996. doi:10.1371/journal.pone.0077996 
Fox, M.T. 2016. Gastrointestinal parasites of cattle. in: The Merck veterinary manual, 11th 
edition. S.E. Aiello and M.A. Moses. ed. Merck & Co., Inc, Kenilworth, NJ.  
Fox, M.T., D. Gerreili, S.R. Pitt, D.E. Jacobs, M. Gill, and D.L. Gale.  1989.  Ostertagia ostertagi 
infection in  the  calf:  effects of a  trickle  challenge on appetite,  digestibility,  rate  of  
passage  of digesta and  liveweight gain.  Res. Vet. Sci. 47:294-298. 
Frechette, J. L., and P. Lamothe. 1981. Milk production effect of a morantel tartrate treatment at 
calving in dairy cows with subclinical parasitism. Can. Vet. J. 22:252-254. 
Freidman, P.A., E.G., Platzer. 1978. Interaction of anthelmintic benzimidazoles and 
benzimidazole derivatives with bovine brain tubulin. Biochem Biophys Acta 44:605-614. 
doi:10.1016/0304-4165(78)90334-3 
Funston, R.N., D.M. Larson, and K.A. Vonnahme. 2009. Effects of maternal nutrition on 
conceptus growth and offspring performance: Implications for beef cattle production. J. 
99 
Anim. Sci. 88(E. Suppl.):E205-E215. doi:10.2527/jas.2009-2351. doi:10.2527/jas.2009-
2351 
Gardner, B.A., H.G. Dolezal, L.K. Bryant, F.N. Owens. And R.A. Smith. 1999. Health of 
finishing steers: Effects on performance, carcass traits, and meat tenderness. J. Anim. Sci. 
77:3168-3175 doi:10.2527/1999.77123168x.  
Gasbarre, L.C., E.A. Leighton, and T. Sonstegard. 2001. Role of the bovine immune system and 
genome in resistance to gastrointestinal nematodes. Vet. Parasitol. 98:51-64. 
doi:10.1016/S0304-4017(01)00423-X 
Gasbarre, L.C., L.L. Smith, J.R Lichtenfels, and P.A. Pilitt. 2009. The identification of cattle 
nematode parasites resistant to multiple classes of anthelmintics in a commercial cattle 
population in the US. Vet. Parasiol. 166:281-285. doi:10.1016/j.vetpar.2009.08.018 
Geary, T. G., Conder, G. A., & Bishop, B. 2004. The changing landscape of antiparasitic drug 
discovery for veterinary medicine. Trends in Parastiol. 20(10):449-455. 
doi:10.1016/j.pt.2004.08.003 
Geary, T. G., S. M. Sims, E. M. Thomas, L. Vanover, J.P. Davis, C.A. Winterrowd, R.D. Klein, 
N.F.H Ho, and D.P. Thompson. 1993. Haemonchus contortus: ivermectin-induced 
paralysis of the pharynx. Exp. Parasitol. 77:88-96. doi:10.1006/expr.1993.1064 
Geary, T.G., N.C. Sangster, and D.P. Thompson. 1999. Frontiers in anthelmintic pharmacology. 
Vet. Parasitol. 84:275-295. doi:10.1016/S0304-4017(99)00042-4 
Gibbs, H.C. 1980. Persistence on pasture of the infective larvae of nematodes parasitizing Maine 
dairy cattle. Am. J. Vet. Res. 41(10):1694-1695 
Gibbs, J., R.C. Young, G.P. Smith.  1973.  Cholecystokinin decreases food intake in rats. J. 
Comp. Physiol.  Psychol. 84:488-495. doi:10.1002/j.1550-8528.1997.tb00305.x 
Gill, J.H. and E. Lacey. 1998. Avermectin resistance to trichostrongyloid nematodes. Int. J. 
Parastiol. 28:863-877. doi:10.1016/S0020-7519(98)00068-X 
Gordon, H.M. 1948. The epidemiology of parasitic diseases, with special reference to studies 
with nematode parasites of sheep. Aus. Vet. J. 45:17-45. doi:10.1111/j.1751-
0813.1948.tb01569.x 
Greer, A.W., F. Kenyon, D.J. Bartley, E.B. Jackson, Y. Gordon, A.A. Donnan, D.W. McBean, 
and F. Jackson.  2009. Development and field evaluation of a decision support model for 
anthelmintic treatments as part of a targeted selective treatment (TST) regime in lambs. 
Vet. Parasitol. 164:12–20. doi:10.1016/j.vetpar.2009.04.017 
Gregory, P.C. 1985.  Parasitic infection and stomach motility: relation to intestinal motility and 
food intake.  Vet. Res. Commun. 1:267-286. 
100 
Hawkins, J.A. 1993. Economic benefits of parasite control in cattle. Vet. Parasitol. 46:159-173. 
doi:10.1016/0304-4017(93)90056-S 
Herd, R.P., W.G. Queen, G.A. Majewski. 1992. Sex-related susceptibility of bulls to 
gastrointestinal parasites. Vet. Parasitol. 44:119-125. doi:10.1016/0304-4017(92)90150-8 
Herlich, H. 1980.  Ostertagia ostertagi infection and reinfection in cattle of different ages. Am. J. 
Vet. Res. 41:259-261. 
Hersom, M.J., R.O. Meyer, and J.N. Carter. 2011. Influence on weaning weights of nursing beef 
cattle calves de-wormed 90 days prior to weaning. Livestock Science 136:270-272. 
doi:10.1016/j.livsci.2010.07.024. 
Hess, B.W., S.L. Lake, E.J. Scholljegerdes, T.R. Weston, V. Nayigihugu, J.D.C. Molle, and G.E. 
Moss. 2005. Nutritional controls of beef cow reproduction. J. Anim. Sci. 
83L(E.Suppl.):E90-E106. doi:10.2527/2005.8313_supplE90x 
Holmes, P. H. 1986. Pathophysiology of nematode infections. In Proceedings of The Sixth 
International Congress of Parasitology, Ed. M. J. Howell. Canberra: Australian Academy 
of Science. 
Holmes, P. H., J.D. Dargie, J.M. Maclean, and W. Mulligan. 1968. The anaemia in fascioliasis: 
experiments with 51Cr-labelled red cells. J. Comp. Pathol. 78:415-420. 
doi:10.1016/0021-9975(68)90039-X 
Hosking, B.C., T.G. Watson, D.M. Leathwick. 1996. Multigeneric resistance to oxfendazole by 
nematodes in cattle. Vet. Rec. 138:67-68. 
Houdijk, J.G.M., F. Jackson, R.L. Coop, and I. Kyriazakis. 2006. Rapid improvement of 
immunity to Teladorsagia circumcincta is achieved through a reduction in the demand for 
protein in lactating ewes. Int. J. Parasitol. 36:219-227. doi:10.1016/j.ijpara.2005.09.014 
Irsik, M. 2012. Gastrointestinal Parasites of Beef Cattle. University of Florida College of 
Veterinary Medicine. 
Jackson, F. 1993. Anthelmintic resistance—the state of play. Brit. Vet. J. 149:123–138. 
doi:10.1016/S0007-1935(05)80083-1 
Jackson, F., E. Jackson, R.L. Coop, and J. Huntley. 1992. Interactions between Teladorsagia 
circumcincta and Trichostrongylus vitrinus infections in young lambs. Res. Vet. Sci. 
53:363-370. 
Kaminsky, R. L. Rufener, J. Bouvier, R. Lizundia, S. Schorderet, and H. Sager. 2013. Worms – 
A ‘license to kill”. Vet. Parasitol. 195:286-291. doi:10.1016/0034-5288(92)90141-N 
Kaplan, R.M. 2004. Drug resistance in nematodes of veterinary importance: a status report. 
Trends in Parasitol. 20(10):477-481. doi:10.1016/j.pt.2004.08.001 
101 
Keymer, A.E. and Hiorns, R.W. 1986. Heligmosomoides polygyrus (Nematoda): the dynamics 
of primary and repeated infection in outbred mice. Proceedings of the Royal Society of 
London. 229:47–67. doi:10.1098/rspb.1986.0074 
Kill, L.K., E.M. Mousel, R.A. Cushman, and G.A. Perry. 2012. Effect of heifer calving date on 
longevity and life time productivity. J. Anim. Sci. 95(Suppl. 2):131(Abstr.).  
Klass, M.R. 1977. Aging in the nematode Caenorhabditis Elegans: major biological and 
environmental factors influencing life span. Mech. Ageing. Dev. 6:413-429. 
doi:10.1016/0047-6374(77)90043-4 
Klesius, P.H. 1988. Immunity to Ostertagia ostertagi. Vet. Parasitol. 27:159-167. 
doi:10.1016/0304-4017(88)90071-4  
Kohler, P. 2001. The biochemical basis of anthelmintic action and resistance. Int. J. Parasitol. 
31:336-345 doi:10.1016/S0020-7519(01)00131-X 
Kohler, P. and R. Bachmann. 1981. Intestinal tubulin as possible target for the chemotherapeutic 
action of mebendazole in parasitic nematodes. Mol. Biochem. Parasitol. 4:325-336. 
doi:10.1016/0166-6851(81)90064-5 
Krecek, R.C., R. Hartman, H.T. Groeneveld, and A. Thorne. 1995. Microclimate effect on 
vertical migration of Haemonchus contortus and Haemonchus placei third-stage larvae on 
irrigated Kikuyu pasture. Onderstepoort J. Vet. Res. 62:117-122. 
Kwa, M.S.G., J.G. Veenstra, and M.H. Roos. 1993. Molecular characterization of β-tubulin 
genes present in benzimidazole-resistant population of Haemonchus contortus. Mol. 
Biochem. Parasitol. 60:133-144. doi:10.1016/0166-6851(93)90036-W 
Lacey, E. 1988. The role of the cytoskeletal protein, tubulin, in the mode of action and 
mechanism of drug resistance to benzimidazoles. Int. J. Parasitol. 18:885-936. 
doi:10.1016/0020-7519(88)90175-0 
Larson, R.L., L.R. Corah, M.F. Spire, and R.C. Cochran. 1995. Effect of treatment with 
ivermectin on reproductive performance of yearling beef heifers. Theriogenology. 
44:189-197. doi:10.1016/0093-691X(95)00168-8  
Lawrence, J.D. and M.A. Ibarburu. 2007. Economic analysis of pharmaceutical technologies in 
modern beef production. Proceeding of the NCCC-134 Conference on Applied 
Commodity Price Analysis, Forecasting, and Market Risk Management. Chicago, IL.  
Le Jambre, L.F. 2006. Eradication of targeted species of internal parasites. Vet. Parasitol. 
139:360-370. doi:10.1016/j.vetpar.2006.04.034 
Le Jambre, L.F., J.H. Gill, I.J. Lenane, and P.Baker. 2000. Inheritance of avermectin resistance 
in Haemonchus contortus. Int. J. Parasitol. 30:105-111. doi:10.1016/S0020-
7519(99)00172-1 
102 
Leighton, E.A., K.D. Murrell, and L.C. Gasbarre. 1989. Evidence for genetic control of 
nematode egg-shedding. J. Parsitol. 75(4):498-504. 
Leng, R.A. 1981. Nutrition and metabolism of parasitized and non-parasitized ruminants. Some 
approaches for studying mode of action of parasites. In: Isotopes and Radiation in 
Parasitology 4. International Atomic Energy Agency, Viennca. pp. 191-206. 
Loveridge, B., M. McArthur, P.B. McKenna, and B. Mariadass. 2003. Probably multigeneric 
resistance to macrocyclic lactone anthelmitics in cattle in New Zealand. N. Z. Vet. J. 
51(3):139-141. doi:10.1080/00480169.2003.36353 
Loyacano, A.F., J.C. Williams, J. Gurie and A.A. DeRosa. 2002. Effect of gastrointestinal 
nematode and liver fluke infections on weight gain and reproductive performance of beef 
heifers. Vet. Parasitol. 107:227-234. doi:10.1016/S0304-4017(02)00130-9 
MacDonald, T.T. and A. Ferguson. 1978. Small intestinal epithelial cell kinetics and protozoal 
infection in mice. J. Gastroenterol. 74:496-500. doi:00165085/78/7403-0496 
MacRae, J.C., J.S. Smith, G.A.M. Sharman, W. Corrigall, and R.L. Coop. 1982. Energy 
metabolism of lambs infected with Trichostrongylus colubriformis. In: A. Ekern and F. 
Sundstel, Energy Metabolism of Farm Animals, European Association of Animal 
Production Publication no. 29. Ed. Aas, Norway: The Agricultural University of Norway. 
pp. 112-115.  
Martin, R.J. 1997. Modes of Action of Anthelmintic Drugs. Vet. J. 154:11-34. 
doi:10.1016/S1090-0233(05)80005-X 
McArthur, M.J. and C.R. Reinemeyer. 2014. Herding the U.S. cattle industry toward a paradigm 
shift in parasite control. Vet. Parasitol. 204:34-43. doi:10.1016/j.vetpar.2013.12.021 
McKellar, Q.A., F. Jackson. 2004. Veterinary anthelmintics: old and new. Trends Parastiol. 
20:456-461. doi:10.1016/j.pt.2004.08.002 
McKenna, B.P. and B.H. Simpson. 1987. The estimation of gastrointestinal stronglyle worm 
burdens in young sheep flocks: a new approach to the interpretation of faecal egg counts 
II. evaluation. N. Z. Vet. J. 35(6):98-100.  
Mejia, M., A. Gonzalez-Iglasias, G.S. Diaz-Torga, P. Villafane, N. Formia, C. Libertun, D. 
Becu-Villalobos, and I.M. Lacau- Mengido. 1999. Effects of continuous ivermectin 
treatment from birth to puberty on growth and reproduction in dairy heifers. J. Anim. Sci. 
77:1329-1334. doi:10.2527/1999.7761329x 
Mejia, M.E., B.M. Fernandez Igartua, E.E. Schmidt, and J. Cabaret. 2003. Multispecies and 
multiple anthelmintic resistance on cattle nematodes in a farm in Argentina: the 
beginning of high resistance? Vet. Res. 34:461-467. doi:10.1051/vetres:2003018 
103 
Michel, J.F. 1976. The epidemiology and control of some nematode infections in grazing 
animals. Adv. Parasitol. 14:355-- 387. doi:10.1016/S0065-308X(08)60517-5 
Miller, F.M., H.T. Blair, G.W. Reynolds, D.K. Revell. 1998. The role of cysteine in the 
increased parasite susceptibility of Romney sheep selected for hogget fleece-weight. 
Proc. N.Z. Soc. Anim. Prod. 58:150-153. 
Morely, F.H.W. and A.D. Donald. 1980. Farm management and systems of helminth control. 
Vet. Parasitol. 6:105-134. doi:10.1016/0304-4017(80)90040-0 
Morris, R.S. and W.E. Marsh. 1994. The relationship between infections, diseases and their 
economic effects. In: Perry, B.D., Hansen, J.W., (Eds.), Modelling vector borne and other 
parasitic diseases. Proc. Workshop organized by ILRAD in collaboration with FAO, 
Nairobi, Kenya, 23–27 November 1992, International Laboratory for Research on 
Animal Diseases, pp. 199–213. 
Murphy, T.M., K.N. Fahy, A. McAuliffe, A.B. Forbes, T.A. Clegg and D.J. O’Brien. 2006. A 
study of helminth parasites in culled cows from Ireland. Prevent. Vet. Med. 76:1-10. 
doi:10.1016/j.prevetmed.2006.04.005 
Myers, G.H. 1988. Strategies to control internal parasites in cattle and swine. J. Anim. Sci. 
66:1555–1564. doi:10.2527/jas1988.6661555x 
Niezen, J.H., W.A.G. Charleston, J. Hodgson, C.M. Miller, T.S. Waghorn, and H.A. Robertson. 
1998. Effect of plant species on the larvae of gastrointestinal nematodes which parasitize 
sheep. I. J. Parasitol. 28:791-803. doi:10.1016/S0020-7519(98)00019-8 
Njue, A.I, and R.K. Prichard. 2004. Efficacy of ivermectin in calves against a resistant Cooperia 
oncophora field isolate. Parastiol. Res. 93:419-422.  
O’Connor, L.J., S.W. Walkden-Brown, L.P. Kahn. Ecology of the free-living stages of major 
trichostrongylid parasites of sheep. Vet. Parasitol. 142:1-15. 
doi:10.1016/j.vetpar.2006.08.035 
Peel D.S. and D. Doye. 2008. Cull cow grazing and marketing opportunities. Oklahoma 
Cooperative Extension Service Fact Sheet. AGEC 613. 
Perry, B.D. and T.F. Randolph. 1999. Improving the assessment of the economic impact of 
parasitic diseases and their control in production animals. Vet. Parasitol. 84:145-168. 
doi:10.1016/S0304-4017(99)00040-0 
Pfeifer, M.L., J.C. Baker, J.T. Seeger, D.A. Blasi, and G.E. Jr. Newdigger. 1999. Evaluation of 
springtime deworming strategies for beef cow/calf pairs. Kansas Agricultural Experiment 
Station Research Reports: Vol. 0:Iss. 1. 
104 
Poppi, D.P., J.C. Macrae, A. Brewer, and R.L. Coop. 1986. Nitrogen transactions in the digestive 
tract of lambs exposed to the intestinal parasite Trichostrongylus colubriformis. Brit. J. of 
Nut. 55:593-602. doi:10.1079/BJN19860064 
Powers, K.G., I.B. Woods, J. Eckert, T. Gibson, and H.J. Smith. 1982. World Association for the 
Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating the 
efficacy of anthelmintics in ruminants (bovine and ovine). Vet. Parasitol. 10:265-284. 
doi:10.1016/0304-4017(82)90078-4 
Prichard, R.K. 2001. Genetic variability following selection of Haemonchus contortus with 
anthelmintics. Trends in Parastiol. 17:445-453. doi:10.1016/S1471-4922(01)01983-3 
Purvis, H.T. and J.C. Whittier. 1996. Effects of ionophore feeding and anthelmintic 
administration on age and weight at puberty in spring-born beef heifers. J. Anim. Sci. 
74:736-744. doi:10.2527/1996.744736x 
Purvis, H.T., J.C. Whittier, S.L. Boyles, L.J. Johnson, H.D. Ritchie, S.R. Rust D.B. Faulkner, 
R.P. Lemenager, and K.S. Hendrix. 1994. Weight gain and reproductive performance of 
spring-born beef heifer calves intraruminally administered Oxfedazole. J. Anim Sci. 
72:817-823. doi:10.2527/1994.724817x 
Randall, R.W. and H.C. Gibbs. 1981. Effect of clinical and sub-clinical gastrointestinal 
helminthiasis on digestion and energy metabolism in calves. Am. J. of Vet. Res. 42: 
173C-1734. 
Rehbein, S., D.G. Baggot, E.G. Johnson, B.N. Kunkle, T.A. Yazwinski, S. Yoon, L.G. Cramer 
and M.D. Soll. 2013a. Nematode burdens of pastured cattle treated once at turnout with 
eprinomectin extended-release injection. Vet. Parastiol. 192:321-331.  
doi:10.1016/j.vetpar.2012.11.038 
Rehbein, S., D.G. Baggot, G.C. Royer, S. Yoon, L.G. Cramer, M.D. Soll. 2013b. The efficacy of 
eprinomectin extended-release injection against induced infection of developing (fourth-
stage larvae) and adult nematode parasites of cattle. Vet. Parasitol. 192:338-345. 
doi:10.1016/j.vetpar.2012.11.041 
Reinhardt, C. D., J. P. Hutcheson, and W. T. Nichols. 2006. A fenbendazole oral drench in 
addition to an ivermectin pour-on reduces parasite burden and improves feedlot and 
carcass performance of finishing heifers compared with endectocides alone. J. Anim. Sci. 
84:2243-2250. doi:10.2527/jas.2005-598 
Reinhardt, C. D., W. D. Busby, and L. R. Corah. 2009. Relationship of various incoming cattle 
traits with feedlot performance and carcass traits. J. Anim. Sci. 87(9):3030-3042. 
doi:10.2527/jas.2008-1293 
105 
Rickard, L.G., G.L. Zimmerman, E.P. Hoberg and D.H. Wallace. 1991. Effect of ivermectin 
delivered from a sustained-release bolus on the productivity of beef cattle in Oregon. Vet. 
Parasitol. 39:267-277. doi:10.1016/0304-4017(91)90043-U 
Roberts, F.H.S., P.J. O’Sullivan, and R.F. Riek. 1952. The epidemiology of parasitic gastro-
enteritis of cattle. Aust. J. of Agric. Research. 3(2):197-226. doi:10.1071/AR9520187 
Roos, M.H., J.A. Boersema, F.H.M. Borgsteede, J. Cornelissen, M. Taylor, and E.J. Ruitenberg. 
1990. Molecular analysis of selection for benzimidazole resistance in the sheep parasite 
Haemonchus contortus. Mol. Biochem. Parasitol. 43:77-88. doi:10.1016/0166-
6851(90)90132-6 
Rowe, J.B., E.M. Abbott, J.D. Dargie, and P.H. Holmes. 1982. The effect of haemonchosis and 
blood loss into the abomasum on nitrogen digestion in sheep. Proceedings of the 
Nutrition Society 41:74A. doi:10.1079/BJN19880016 
Rowe, J.B., J.V. Nolan, G. de Chaneet, E. Teleni, and P.H. Holmes. 1988. The effect of 
haemonchosis and blood loss into the abomasum on digestion in sheep. Brit. J. of Nut. 
59:125-139. doi:10.1079/BJN19880016 
Sanchez, J., A. Nødtvedt, I. Dohoo, & L. DesCoteaux. 2002. The effect of eprinomectin 
treatment at calving on reproduction parameters in adult dairy cows in Canada. Prev. Vet. 
Med. 56:165-177. doi:10.1016/S0167-5877(02)00118-6 
Sangster, N. C., & Gill, J. 1999. Pharmacology of anthelmintic resistance. Parasitol Today 
154:141-146. doi:10.1016/S0169-4758(99)01413-1 
Sangster, N.C. 1999. Anthelmintic resistance: past, present and future. Int. J. Parasitol. 29:115-
124. doi:10.1016/S0020-7519(98)00188-X 
Sanson, D.W., A.A. DeRosa, G.R. Oremus and L.D. Foil. 2003. Effect of horn fly and internal 
parasite control on growth of beef heifers. Vet. Parasitol. 117:291-300. 
doi:10.1016/j.vetpar.2003.09.005 
Saz, H.J., E. Bueding. 1966. Relationship between anthelmintic effects and biochemical and 
physiological mechanisms. Pharmacol. Rev. 18:871-894.  
Schad, G.A. 1977. The role of arrested development in the regulation of nematode populations. 
In: Regulations of Parasite Populations. Academic Press, New York, San Francisco, 
London, pp. 111-67. 
Shoop, W.L. 1993. Ivermectin resistance. Parsitol. Today. 9(5):154-159. doi:10.1016/0169-
4758(93)90136-4 
Short, R.E. and D.C. Adams. 1988. Nutritional and hormonal interrelationships in beef cattle 
reproduction. Can. J. Anim. Sci. 68:29-39. doi:10.4141/cjas88-003 
106 
Silva, B.F., M.R.V. Amarante, S.M. Kadri, J.R. Carrijo-Maud, and A.F.T. Amarante. 2008. 
Vertical migration of Haemonchus contortus third stage larvae on Brachiaria decumbens 
grass. Vet. Parasitol. 158:85-92. doi:10.1016/j.vetpar.2008.08.009 
Skogerboe, T.L., L. Thompson, J.M. Cunningham, A.C. Brake and V.K. Karle. 2000. The 
effectiveness of a single dose of doramectin pour-on in the control of gastrointestinal 
nematodes in yearling stocker cattle. Vet. Parasitol. 87:173-181. doi:10.1016/S0304-
4017(99)00162-4 
Smith, G. and B.T. Grengell. 1985. The population biology of Ostertagia ostertagi. Parasitol. 
Today. 1(3):76-81. doi:10.1016/0169-4758(85)90047-X 
Smith, H.J. and R.M. Archibald. 1968. The effects of age and previous infection on the 
development of gastrointestinal parasitism in cattle. Can. J. Comp. Med. 32:511-517.  
Smith, R. A., K. C. Rogers, S. Huse, M. I. Wray, R. T. Brandt Jr, J. P. Hutcheson, W. T. Nichols, 
R. F. Taylor, J. R. Rains, and C. T. McCauley. 2000. Pasture deworming and (or) 
subsequent feedlot deworming with fenbendazole. I. Effects on grazing performance, 
feedlot performance and carcass traits of yearling steers. Bovine Practitioner 104-114. 
Solls, M.D., B.N. Kunkle, G.C. Royer, T.A. Yazwinski, D.G. Baggot, T.A. Wehner, S. Yoon, 
L.G.  Cramer and S. Rehbein. 2013. An eprinomectin extended-release injection 
formulation providing nematode control in cattle for up to 150 days. Vet. Parasitol. 
192:313-320. doi:10.1016/j.vetpar.2012.11.037 
Southcott, W.H., G.W. Major, and I.A. Barger. 1976. Seasonal pasture contamination and 
availability of nematodes for grazing sheep. Aust. J. Agric. Res. 27:277-286. 
doi:10.1071/AR9760277 
Stacey, B.R., K.C. Barnes, and D.L. Lalman. 1999. Performance of calves deowmred with 
Ivomec SR Bolus® compared with Ivomec Pour-on®. Oklahoma State University 
Animal Science Research Report. p. 225-257. 
Stafford, K. and G.C. Coles. 1999. Nematodes control practices and anthelmintic resistance in 
ddairy calves in the southwest of England. Vet. Rec. 144:659-661. 
doi:10.1136/vr.144.24.659 
Steelman, C.D., M.A. Brown, E.E. Gbur, and G. Tolley. The effects of hair density of beef cattle 
on Haematobia irritans horn fly populations. Vet. Med. Entomol. 11:257-264. 
doi:10.1111/j.1365-2915.1997.tb00404.x  
Stromberg, B.E. 1997. Environmental factors influencing transmission. Vet Parasitol. 72:247-
264. doi:10.1016/S0304-4017(97)00100-3 
Stromberg, B.E. and L.C. Gasbarre. 2006. Gastrointestinal nematode control programs with an 
emphasis on cattle. Vet. Clin. Food. Anim. 22:543-565. doi:10.1016/j.cvfa.2006.08.003 
107 
Stromberg, B.E., and R.M. Corwin. 1993. Epizootiology of Ostertagia ostertagi in cow-calf 
production systems in the American Midwest. Vet. Parasitol. 46:297-302. 
doi:10.1016/0304-4017(93)90067-W  
Stromberg, B.E., R.J. Vatthauer, J.C. Schlotthauer, G.H. Meyers, D.L. Haggard, V.L. King, and 
H. Hanke. 1997. Production responses following strategic parasite control in beef 
cow/calf herd. Vet. Parasitol. 68:315-322. doi:10.1016/S0304-4017(96)01081-3 
Stryer, L., J.L. Tymoczko, J.M. Berg. Biochemistry. 2002. 5th edition. ed. W.H. Freeman, New 
York, New York. 
Stuedemann, J.A., H. Ciordia, G.H. Meyers, H.C. McCampbell. 1989. Effect of a single 
strategically timed dose of fenbendazole in cow and calf performance. Vet. Parasitol. 
34:77-86. doi:10.1016/0304-4017(89)90167-2 
Sutherland, I., and I., Scott. 2009. Gastrointestinal nematodes of sheep and cattle: biology and 
control. ed. Wiley-Blackwell, West Sussex, UK. 
Sutphin, G.L. and M. Kaeberlein. Dietary restriction by bacterial deprivation increases life span 
in wild-derived nematodes. Expe. Geront. 43:130-135. doi:10.1016/j.exger.2007.10.019 
Suttle N.F., D.P. Knox, F. Jackson, R.L. Coop, and K.W. Angus. 1992b. Effects of dietary 
molybdenum on nematode and host during Trichostrongylus vitrinus infection in lambs. 
Res. Vet. Sci. 52:224-229. doi:10.1016/0034-5288(92)90014-S 
Suttle N.F., D.P. Knox, K.W. Angus, F. Jackson, and R.L. Coop. 1992a. Effects of dietary 
molybdenum on nematode and host during Haemonchus contortus infection in lambs. 
Res. Vet. Sci. 52:23-235. doi:10.1016/0034-5288(92)90015-T 
Svetic, A., Madden, K.B., Zhou, X., Lu, P., Katona, I.M., Finkelman, F.D., Urban Jr., J.F., 
Gause, W.C., 1993. A primary intestinal helminth infection rapidly induces a gut-
associated elevation of Th2-associated cytokinesand IL-3. J. Immunol. 150:3434–3441. 
Sykes A.R. 1983. Effects of parasitism on metabolism in the sheep. In:  The Sheep Production.  
Nottingham Easter School of Agricultural Science. Ed. W. Haresign.  London:  
Butterworths. No 35. pp.  317 -334.   
Sykes, A.R. and R.L. Coop. 1976. Intake and utilization of food by growing lambs with parasitic 
damage to the small intestine caused by daily dosing with Trichostrongylus colubriformis 
larvae. J. Ag. Sci., Cambridge. 86:507-515. doi:10.1017/S0021859600061049 
Sykes, A.R., R.L. Coop, and K.W. Angus. 1977. The influence of chronic Ostertagia 
circumcincta infection on the skeleton of growing sheep. J. Comp. Pathol. 87:521-529. 
doi:10.1016/0021-9975(77)90058-5 
108 
Symons, L.E.A. and W.O. Jones. 1975. Skeletal muscle, liver, and wool protein synthesis by 
sheep infected by the nematode Trichostrongylus colubriformis. Aust. J. Agric. Res. 
26:1063-1072. doi:10.1071/AR9751063 
Taylor, M.A., K.R. Hunt, and K.L. Goodyear. 2002. Anthelmintic resistance detection methods. 
Vet. Parasitol. 103:183-194. doi:10.1016/S0304-4017(01)00604-5 
Taylor, M.A., R.L. Coop, R.L. Wall. 2007. Veterinary parasitology. ed. Blackwell Publishing, 
Oxford, UK. 
Trehal, S. S., J.L. Talley, D.K. Sherrill, T. Spore, R.N. Wahl, W.R. Hollenbeck, and D. Blasi. 
2017. Horn fly control and growth implants are effective strategies for heifers grazing 
Flint Hills pasture. Kansas Agricultural Experiment Station Research Reports: Vol. 3:Iss. 
1. https://doi.org/10.4148/2378-5977.1337 
USDA NAHMS. 2010. 2007-08 Beef Cow-calf Studies, Part IV: Reference of Beef Cow-calf 
Management Practices in the United States. 
Utley, P.R., T.B. Stewart, H. Ciordia and W.C. McCormick. 1974. Effect of anthelmintic 
treatment on feedlot performance of growing and finishing heifers. J. Anim. Sci. 
38(5):984-990. doi:10.2527/jas1974.385984x 
van  Wyk,  J.A. and  G.F. Bath.  2002.  The FAMACHA system for managing haemonchosis in 
sheep and goats by clinically identifying individual animals for treatment. Vet. Res. 
33:509–529. doi:10.1051/vetres:2002036 
van der Voort, M., J. Charlier, L. Lauwers, J. Vercruysse, G. Van Huylenbroeck, and J. Van 
Meensel. Conceptual framework for analysis farm-specific economic effects of helminth 
infections in ruminants and control strategies. Prev. Vet. Med. 109:228-235. 
doi:10.1016/j.prevetmed.2012.10.017 
Van Wyk, J.A. 2001. Refugia-overlooked as perhaps the most potent factor concerning the 
development of anthelmintic resistance. Onderstepoort J. Vet. Res. 68:55-67. 
Vercruysse, J. and E. Claerebout. 2001. Treatment vs non-treatment of helminth infections in 
cattle: defining the threshold. Vet. Parasitol. 98:195-214. doi:10.1016/S0304-
4017(01)00431-9 
Vercruysse, J., P. Dorny, P. Berghen, and J. Geeraerts. 1986. Abomasal parasites in dairy cows 
in Belgium. Vet. Parasitol. 22:285-291. doi:10.1016/S0304-4017(00)00232-6 
Vermunt, J.J., D.M. West, W.E. Pomroy. 1995. Multiple resistances to ivermectin and 
oxfendazole in Cooperia species of cattle  in New Zealand. Vet. Rec. 137:43-45. 
doi:10.1136/vr.137.2.43 
Vesco, A.C., A.K. Sexten, C.S. Weibert and B.E. Oleen. 2015. Evaluation of the productivity of 
a single subcutaneous injection of LongRange in stocker calves compared with a positive 
109 
(Dectomax) and negative (Saline) control. Kansas Agricultural Experiment Station 
Research Reports. Vol 1:Iss 1. doi:10.4148/2378-5977.1018 
Waller, P. J. 2006. From discovery to development: current industry perspectives for the 
development of novel methods of helminth control in livestock. Vet. Parasitol. 139(1):1-
14. doi:10.1016/j.vetpar.2006.02.036 
Waller, P.J. 1994. The development of anthelmintic resistance in ruminant livestock. Acta Trop. 
56:233-243. doi:10.1016/0001-706X(94)90065-5 
Waller, P.J. 1997. Anthelmintic resistance. Vet. Parastiol. 72:391-412. doi:10.1016/S0304-
4017(97)00107-6 
Wang, Q., T.A. Meyer, S.T. Boyce, J.J. Wang, X.Y. Sun, G. Tiao, J.E. Fischer, and P.O. 
Hasselgren. 1998. Endotoxemia in mice stimulates production of complement C3 and 
serum amyloid in mucosa of small intestine Am. J. Physiol. Regul. Integr. Comp. 
Physiol. 44:R1584-R1592.  
Ward, J.K., D.L. Ferguson, A.M. Parkhurst, J. Berthelsen, and M.J. Nelson. 1991. Internal 
parasite levels and response to anthelmintic treatment by beef cows and calves. J. Anim. 
Sci. 69:917-922. doi:10.2527/1991.693917x 
Watson, E.A. 2016. Effects of anthelmintic treatments on performance indicators in stocker 
calves. Honors College Thesis 9.  
White, B.J., J.D. Anderson, R.L. Larson, K.C. Olson, and D.U. Thompson. 2007. The cow-calf 
operation retained ownership decision. Prof. Anim. Sci. 23:18-28. doi:10.1532/S1080-
7446(15)30932-3 
Williams JC, A.F., Loyacano. 2001. Internal parasites of cattle in Louisiana and other southern 
states. LSU Research and Extension Research Information Sheet #104, p. 1–20. 
Williams, J.C. 1997. Anthelmintic treatment strategies: current status and future. Vet. Parasitol. 
72:461-477. doi:10.1016/S0304-4017(97)00111-8 
Williams, J.C. and F.R. Bilkovich. 1971. Development and survival of infective larve of the 
cattle nematode, Ostertagia ostertagi. J. Parastiol. 57(2):327-338. doi:10.2307/3278037 
Williams, J.C., A.F. Loyacano, S.D. Broussard and D.F. Coombs. 1995. Effect of treatment with 
an ivermectin sustained-bolus on productivity of stocker beef calves. Vet. Parasitol. 
58:75-82. doi:10.1016/0304-4017(94)00707-J  
Wilson, R.A.. A. Zolnai, P. Rudas, and L.V. Frenyo. 1996. T-cell subsets in blood and lymphoid 
tissues obtained from fetal calves, maturing calves, and adult bovine. Vet. Immunol. 
Immunopathol. 53:49-60. doi:10.1016/0165-2427(95)05543-6 
110 
Wiltbank, J. N. 1970. Research needs in beef cattle reproduction. J. Anim. Sci. 31(4):755-762. 
doi:10.2527/jas1970.314755x 
Wohlgemuth, K., M. Biondini, A. Misek, and L. Anderson. 1990. Deworming beef cows and 
calves with Fenbendazole: effect on weaning weight of calves. Farm. Res. 48(4):27-30. 
Wolstenholme, A.J., I. Fairweather, R. Prichard, G. von Samsom-Himmelstjerna, and N.C. 
Sangster. 2004. Drug resistance in veterinary helminths. Trends in Parasitol. 20:469-476. 
doi:10.1016/j.pt.2004.07.010 
Wood, I.B., N.K. Amaral, K. Bairden, J.L. Duncan, T. Kassai, J.B. Malone Jr., J.A. Pankavich, 
R.K. Reinecke, O. Slocombe, S.M. Taylor, and J. Vercruysse. 1995. World Association 
for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition of 
guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, 
caprine). Vet. Parasitol. 58:181-213. doi:10.1016/0304-4017(95)00806-2 
Wu, G., F.W. Bazer, T.A. Cudd, C.J. Meininger, and T.E. Spencer. 2004. Maternal nutrition and 
fetal development. J. Nutr. 134(9):2169-2172 
Xu, M. M. Molento, W. Blackhall, P. Ribeiro, R. Beech, and R. Prichard. 1998. Ivermectin 
resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Mol. 
Biochem. Parsiol. 91:327-335. doi:10.1016/S0166-6851(97)00215-6 
Yazwinski, T.A. and C.A. Tucker. 2006. A sampling of factors relative to the epidemiology of 
gastrointestinal nematode parasites of cattle in the United States. Vet. Clin. Food. Anim. 
22:501-527. doi:10.1016/j.cvfa.2006.07.005 
Yazwinski, T.A., C. Tucker, S. Copeland, T. Yazwinski, and F. Guerino. 1999. Dose 
confirmation of moxidectin pour-on against natural nematode infections in lactating dairy 
cows. Vet. Parasitol. 86:223-228. doi:10.1016/S0304-4017(99)00153-3 
Yu, F., L.A. Bruce, A.G. Calder, E. Milne, R.L. Coop, F. Jackson, G.W. Horgan, and J.C. 
Macrae. 2000. Subclinical infection with the nematode Trichostrongylus colubriformis 
increases gastrointestinal tract leucine metabolism and reduces availability of leucine for 
other tissues. J. Anim. Sci. 78:380-390. doi:10.2527/2000.782380x 
Zajac, A.M. 2006. Gastrointestinal nematodes of small ruminants: life cycle, anthelmintics, and 
diagnosis. Vet. Clin. Food Animal. 22:529-541. doi:10.1016/j.cvfa.2006.07.006 
Zajac, A.M., J.W. Hansen, W.D. Whittier, and D.E. Eversole. 1991. The effect of parasite 
control on fertility in beef heifers. Vet. Parasitol. 40:281-291. doi:10.1016/0304-
4017(91)90108-8 
 
 
